Fistful of Weeds™ 50g

(2 customer reviews)

£7.00

Wonderful sweet floral surprise that is packed with ingredients that have been used for millenia in traditional medicine – unfortunately, we are not legally allowed to give any medical links to this product.

Description

Indulge in the refreshing and invigorating aroma of T’n’T Teas® Fistful of Weeds™, a harmonious blend of elderflower, lemongrass, nettle, milk thistle, dandelion, and acacia, carefully crafted to provide a synergy of holistic health benefits. This caffeine-free infusion is not only delightful to the palate but also nurtures your body from within, offering a range of health-enhancing properties.

Unwind and savour the intriguing notes, a true delight for your senses.

The Fistful of Weeds™ refreshing hot and iced herbal tea, a unique and invigorating blend crafted with natural ingredients that promising a unique and exciting flavour experience.

Don’t let the name fool you; it’s a refreshing brew designed to invigorate your senses.

As you sip your Fistful of Weeds™ iced tea, the delicate elderflower leads the way, offering a fragrant and floral introduction. Lemongrass steps in with its lively, zesty notes, reminiscent of a vibrant summer’s day. Nettle adds an creamy depth to the blend, like a walk through a serene forest. Milk thistle and dandelion join the performance with their intriguing herbal complexities. Acacia’s sweetness ties it all together, creating a harmonious and refreshing experience.

Elderflower adds a delicate and floral note, reminiscent of a blossoming garden. Lemongrass brings a zesty and citrusy twist, akin to a lively summer breeze. Nettle contributes an earthy depth, like a tranquil forest stroll. Milk thistle introduces a hint of herbal complexity, adding a layer of intrigue. Dandelion offers a subtle bitter-sweetness, akin to a wildflower field. Acacia’s gentle sweetness complements the other elements, creating harmony.

Disclaimer

This information is provided for educational and informational purposes. It is not provided to diagnose, treat, cure, or prevent any disease. Legally, we are unable to make these claims directly, but we urge you to review the clinical references we list on this site and conduct your own research. These products are intended for dietary supplement purposes only. Whilst we are professional herbalists, and every care has been taken to provide accurate and up-to-date information, as a consumer, you should always consult your healthcare professional before consumption, especially if you are pregnant, nursing, have a medical condition or are taking medications. We do offer free personal consultations for solutions specific to your needs.

Additional information

Weight 50 g

Wellbeing

Fistful of Weeds contains many ingredients regarded as weeds, but that have traditionally been used in folk medicine for a wide range of benefits. Legally, we are unable to list them here.

Safe to drink regularly for a short time, but we are unable, legally, to provide any information without a consultant – please contact us for a free,  private consultation.

Warning: Prepared in an area where Mustard seed & Celery are prepared. Consult a doctor if on medication.

Profile

Colour: A vibrant and lively greenish amber, like a meadow in full bloom.
Aroma: An invigorating blend of floral and herbal notes, reminiscent of a nature walk.
Initial taste: The first sip offers a zesty sweet floral embrace, awakening your palate like a spring morning.
Midtones: Lemongrass joins the party, adding a citrusy twist that’s as lively as a garden in the sun.
Aftertaste: Delicate floral hints linger, leaving a subtle, pleasant sweetness, like a gentle breeze.
Body: Light and revitalising, it’s a dance of natural flavours that’ll refresh your taste buds.
Caffeine content: This blend is caffeine-free, ensuring a relaxing experience.

Sip, savour, and let Fistful of Weeds™ iced herbal tea take you on a refreshing journey in every glass.

Ingredients

Elderflower | Lemongrass | Nettle | Milk Thistle | Dandelion | Acacia

Cruelty-free and vegan product logo100% GMO-Free. Suitable for vegans.

T’n’T Teas® Fistful of Weeds™ uses certified, premium quality professionally mixed ingredients, from the highest quality, medicinal natural herbs from around the world. We pay special attention to the purity of the plants, so we only buy the certified raw materials for our products from reliable, controlled sources, so we can ensure that we minimise contact with foreign substances during storage, transportation, and production.

Warning: Prepared in an area where Mustard seed & Celery are also used. Herbs have medicinal properties that will affect the body but should not replace examination and advice from your medical practitioner. Please check that they are happy for you to drink herbal infusions. If you feel any discomfort, stop immediately and find out the cause (it may not be herbal tea that caused the discomfort!).

This tea contains 100% natural products without allergens or impurities, and no added flavours or colourants, so its consumption should not cause any unpleasant stomach upsets.

Shake well before use.

Certified Origins

Bulgarian flag denoting that one or more ingredients was ethically sourced from Bulgaria. Hungarian flag denoting that one or more ingredients are ethically sourced from Hungary. Polish flag denoting that one or more ingredients was ethically sourced from Poland. Spanish flag denoting that one or more ingredients was ethically sourced from Spain. Turkish flag denoting that one or more ingredients are ethically sourced from Turkey.
Hand-blended & packaged in Shropshire, England.

Preparation

Preparation for a hot cup of tea:

“Sip & Rejuvenate!” – Preparation notes for T’n’T Teas’® Fistful of Weeds™ herbal tea:

  1. Zen space: Seek a cosy corner, indoors or outdoors. This tea is your path to a calming and rejuvenating experience. Set the perfect mood with your choice of location.
  2. Herbal symphony: Measure one tablespoon of our Fistful of Weeds™ tea blend. It’s a botanical ensemble featuring elderflower, lemongrass, nettle, milk thistle, dandelion, and acacia. They’re ready to take centre stage in your cup.
  3. H2O magic: Boil fresh water and let it cool for a moment, aiming for a temperature around 96°C (205°F). This is the backstage preparation for the herbal show.
  4. Flavour dance: Pour the hot water over your tea blend with the grace of a dancer taking the stage. Cover your cup or teapot and let it steep for a mesmerising 10-15 minutes.
  5. Sweetening serenade: If desired, add a touch of honey or a slice of lemon. Think of it as a sweet serenade to complement the herbal orchestra.
  6. Cover & unwind: Keep your cup covered with a lid as the herbal performance unfolds. It’s the prelude to your serene journey.
  7. Strain & rejuvenate: It’s time for the herbal infusion to take the spotlight. Strain the tea blend, and let the rejuvenation commence.
  8. Tranquil sips: Bring your cup close and take that first sip of the herbal symphony. It’s like listening to the soothing melodies of nature.
  9. Encore time: The calm and rejuvenation don’t have to end with just one act. Prepare for another infusion when you desire another soothing performance.
  10. Herbal harmony: Store your tea blend in a tranquil, cool, and dry place, ready to create serene moments whenever you please.

Sip, savour, and let T’n’T Teas’® Fistful of Weeds™ tea serenade your senses into a world of calm and rejuvenation.

 

Preparation for 1 litre of iced tea:

“Nature’s Refreshment” – Preparation notes for T’n’T Teas’® Fistful of Weeds™ iced herbal tea:

Nature’s stage: Find your outdoor oasis, whether it’s a garden, a balcony, or a park bench. This tea is your ticket to a refreshing natural escape.
Tea adventure: Measure one tablespoon of our Fistful of Weeds™ tea blend your botanical companions.
H2O power: Boil fresh water, let it cool for a moment, and aim for around 96°C (205°F). This is the foundation of your refreshing journey.
Flavour infusion: Pour the hot water over your tea blend with the enthusiasm of a waterfall in the wilderness. Cover it and let it steep for 10-15 minutes.
Sweeten the outdoors: After straining it add a touch of honey or a hint of sugar and some drops of lemon juice. Think of it as a gift to Mother Nature.
Jug of joy: Transfer your brewed tea into a large jug. Picture it as a natural elixir, ready to quench your outdoor thirst.
Cool & refresh: Add plenty of ice cubes to your jug, along with three cups of icy cold water. Watch as your steamy infusion transforms into a revitalising elixir.
Sip & embrace nature: Raise your glass to the great outdoors and take a sip of Fistful of Weeds™ iced herbal tea. It’s like capturing the essence of nature in every refreshing gulp.
Repeat the adventure: Your outdoor journey doesn’t have to end with one glass. Prepare another batch whenever you’re craving nature’s refreshment.
Earth-friendly: Respect the environment by disposing of your tea leaves and any waste responsibly. Mother Nature will appreciate it!

Sip, savour, and let T’n’T Teas’® Fistful of Weeds™ iced herbal tea be your gateway to a nature-filled, refreshing adventure.

Clinical References

Clinical evidence of the ingredients found in this product. These are public domain references and do not relate directly to our product.

Acacia

  • Cvitanovic, S., Znaor, L., Perisic, D., and Grbic, D. Hypersensitivity to pollen allergens on the Adriatic coast. Arh.Hig.Rada Toksikol. 2004;55(2-3):147-154.
  • De Zotti, R. and Gubian, F. Asthma and rhinitis in wooding workers. Allergy Asthma Proc 1996;17(4):199-203.
  • Electronic Code of Federal Regulations. Title 21. Part 182 – Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  • Geller, M. and Rosario, N. A. Skin test sensitivity to Acacia pollen in Brazil. Ann.Allergy 1981;47(3):180-181.
  • Goussault, Y., Sharif, A., and Bourrillon, R. Serum albumin biosynthesis and secretion by resting and lectin stimulated human lymphocytes. Biochem Biophys Res Commun. 12-20-1976;73(4):1030-1035.
  • Haridas, V., Hanausek, M., Nishimura, G., Soehnge, H., Gaikwad, A., Narog, M., Spears, E., Zoltaszek, R., Walaszek, Z., and Gutterman, J. U. Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery. J Clin Invest 2004;113(1):65-73.
  • Hausen, B. M. Sensitizing capacity of naturally occurring quinones. V. 2.6-dimethoxy-p-benzoquinone: occurrence and significance as a contact allergen. Contact Dermatitis 1978;4(4):204-213.
  • Howlett BJ, Hill DJ, Knox RB. Cross-reactivity between Acacia (wattle) and rye grass pollen allergens. Detection of allergens in Acacia (wattle) pollen. Clin Allergy. 1982 May;12(3):259-68.
  • Jensen CD, Haskell W, Whittam JH. Long-term effects of water-soluble dietary fiber in the management of hypercholesterolemia in healthy men and women. Am J Cardiol 1997;79:34-7.
  • Lemonnier, M., Goussault, Y., and Bourrillon, R. [Interactions of phytoagglutinins with urinary glycopeptides. Analysis of a glycopeptide inhibitor of phytoagglutinin from Robinia pseudo acacia]. Carbohydr Res 1972;24(2):323-331.
  • Li, S. S., Gao, Z., Feng, X., Jones, S. H., and Hecht, S. M. Plant sterols as selective DNA polymerase beta lyase inhibitors and potentiators of bleomycin cytotoxicity. Bioorg.Med Chem 8-1-2004;12(15):4253-4258.
  • Liam, C. K., Loo, K. L., Wong, C. M., Lim, K. H., and Lee, T. C. Skin prick test reactivity to common aeroallergens in asthmatic patients with and without rhinitis. Respirology. 2002;7(4):345-350.
  • Lo, Y. L., Hsu, C. Y., and Huang, J. D. Comparison of effects of surfactants with other MDR reversing agents on intracellular uptake of epirubicin in Caco-2 cell line. Anticancer Res 1998;18(4C):3005-3009.
  • Lust J. The herb book. New York, NY: Bantam Books, 1999.
  • Padula, P. A. and Friedmann, L. W. Acquired amputation and prostheses before the sixteenth century. Angiology 1987;38(2 Pt 1):133-141.
  • Paufique, L. and Hugonnier, R. [Recurrent iridocyclitis caused by an acacia thorn in the ciliary body. Technic for the extraction of the foreign body]. Bull.Soc Ophtalmol.Fr. 1966;66(5):547-549.
  • Pumhirun, P., Towiwat, P., and Mahakit, P. Aeroallergen sensitivity of Thai patients with allergic rhinitis. Asian Pac.J Allergy Immunol. 1997;15(4):183-185.
  • Sam, C. K., Kesavan, Padmaja, Liam, C. K., Soon, S. C., Lim, A. L., and Ong, E. K. A study of pollen prevalence in relation to pollen allergy in Malaysian asthmatics. Asian Pac.J Allergy Immunol. 1998;16(1):1-4.
  • Shah, B. H., Safdar, B., Virani, S. S., Nawaz, Z., Saeed, S. A., and Gilani, A. H. The antiplatelet aggregatory activity of Acacia nilotica is due to blockade of calcium influx through membrane calcium channels. Gen.Pharmacol 1997;29(2):251-255.
  • Suliaman, F. A., Holmes, W. F., Kwick, S., Khouri, F., and Ratard, R. Pattern of immediate type hypersensitivity reactions in the Eastern Province, Saudi Arabia. Ann.Allergy Asthma Immunol. 1997;78(4):415-418.

Dandelion

  • Agarwal SC, Crook JR, Pepper CB. Herbal remedies — how safe are they? A case report of polymorphic ventricular tachycardia/ventricular fibrillation induced by herbal medication used for obesity. Int J Cardiol 2006;106:260-1.
  • Akhtar, M. S., Khan, Q. M., and Khaliq, T. Effects of Portulaca oleracae (Kulfa) and Taraxacum officinale (Dhudhal) in normoglycaemic and alloxan-treated hyperglycaemic rabbits. J Pak.Med Assoc 1985;35(7):207-210.
  • Baba K, Abe S, Mizuno D. [Antitumor activity of hot water extract of dandelion, Taraxacum officinale-correlation between antitumor activity and timing of administration]. Yakugaku Zasshi 1981;101:538-43.
  • Bohm K. Studies on the choleretic action of some drugs. Azneim-Forsh 1959;9:376-378.
  • Catania, M. A., Oteri, A., Caiello, P., Russo, A., Salvo, F., Giustini, E. S., Caputi, A. P., and Polimeni, G. Hemorrhagic cystitis induced by an herbal mixture. South.Med.J. 2010;103(1):90-92.
  • Chakurski I, Matev M, Koichev A, et al. [Treatment of chronic colitis with an herbal combination of Taraxacum officinale, Hipericum perforatum, Melissa officinaliss, Calendula officinalis and Foeniculum vulgare]. Vutr Boles. 1981;20:51-4.
  • Chen, Z. [Clinical study of 96 cases with chronic hepatitis B treated with jiedu yanggan gao by a double-blind method]. Zhong.Xi.Yi.Jie.He.Za Zhi. 1990;10(2):71-4, 67.
  • Chivato T, Juan F, Montoro A, Laguna R. Anaphylaxis induced by ingestion of a pollen compound. J Investig Allergol Clin Immunol 1996;6:208-9.
  • Clare, B. A., Conroy, R. S., and Spelman, K. The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day. J Altern.Complement Med 2009;15(8):929-934.
  • Cohen SH, Yunginger JW, Rosenberg N, Fink JN. Acute allergic reaction after composite pollen ingestion. J Allergy Clin Immunol 1979;64:270-4.
  • Collier MH, Rogstad SH. Clonal variation in floral stage timing in the common dandelion Taraxacum officinale (Asteraceae). Am J Bot. 2004 Nov;91(11):1828-33.
  • Collins JM and Miller DR. Dandelion green bezoar following antrectomy and vagotomy – case report. J Kansas Med Soc 1966;67(6):303-304.
  • Cuzzolin L, Zaffani S, and Benoni G. Safety implications regarding use of phytomedicines. Eur.J Clin Pharmacol. 2006;62:37-42.
  • Davies, M. G. and Kersey, P. J. Contact allergy to yarrow and dandelion. Contact Dermatitis 1986;14(4):256-257.
  • Electronic Code of Federal Regulations. Title 21. Part 182 — Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  • Fernandez-Gonzalez, D., Gonzalez-Parrado, Z., Vega-Maray, A. M., Valencia-Barrera, R. M., Camazon-Izquierdo, B., De, Nuntiis P., and Mandrioli, P. Platanus pollen allergen, Pla a 1: quantification in the atmosphere and influence on a sensitizing population. Clin Exp Allergy 2010;40(11):1701-1708.
  • Goksu, E., Eken, C., Karadeniz, O., and Kucukyilmaz, O. First report of hypoglycemia secondary to dandelion (Taraxacum officinale) ingestion. Am J Emerg.Med 2010;28(1):111-112.
  • González-Castejón M, Visioli F, Rodriguez-Casado A. Diverse biological activities of dandelion. Nutr Rev. 2012;70(9):534-47.
  • Hagymasi, K., Blazovics, A., Feher, J., Lugasi, A., Kristo, S. T., and Kery, A. The in vitro effect of dandelions antioxidants on microsomal lipid peroxidation. Phytother Res 2000;14(1):43-44.
  • Han, H., He, W., Wang, W., and Gao, B. Inhibitory effect of aqueous Dandelion extract on HIV-1 replication and reverse transcriptase activity. BMC.Complement Altern.Med 2011;11:112.
  • Hata, K., Ishikawa, K., Hori, K., and Konishi, T. Differentiation-inducing activity of lupeol, a lupane-type triterpene from Chinese dandelion root (Hokouei-kon), on a mouse melanoma cell line. Biol Pharm Bull 2000;23(8):962-967.
  • He, W., Han, H., Wang, W., and Gao, B. Anti-influenza virus effect of aqueous extracts from dandelion. Virol.J 2011;8:538.
  • Hook I, McGee A, Henman M, and et al. Evaluation of dandelion for diuretic activity and variation in potassium content. Int J Pharmacog 1993;31(1):29-34.
  • Hu C, Kitts DD. Antioxidant, prooxidant, and cytotoxic activities of solvent-fractionated dandelion (Taraxacum officinale) flower extracts in vitro. J Agric Food Chem 2003;51:301-10.
  • Hu C, Kitts DD. Dandelion (Taraxacum officinale) flower extract suppresses both reactive oxygen species and nitric oxide and prevents lipid oxidation in vitro. Phytomedicine 2005;12:588-97.
  • Hu C, Kitts DD. Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells. Mol Cell Biochem 2004;265:107-13.
  • Huang, Y., Wu, T., Zeng, L., and Li, S. Chinese medicinal herbs for sore throat. Cochrane Database Syst.Rev 2012;3:CD004877.
  • Hussain Z, Waheed A, Qureshi RA, et al. The effect of medicinal plants of Islamabad and Murree region of Pakistan on insulin secretion from INS-1 cells. Phytother Res 2004;18:73-7.
  • Ingber, A. Seasonal allergic contact dermatitis from Taraxacum officinale (dandelion) in an Israeli florist. Contact Dermatitis 2000;43(1):49.
  • Jovanovic M, Mimica-Dukic N, Poljacki M, Boza P. Erythema multiforme due to contact with weeds: a recurrence after patch testing. Contact Dermatitis 2003;48:17-25.
  • Kashiwada Y, Takanaka K, Tsukada H, et al. Sesquiterpene glucosides from anti-leukotriene B4 release fraction of Taraxacum officinale. J Asian Nat Prod Res 2001;3:191-7.
  • Kim, H. M., Lee, E. H., Shin, T. Y., Lee, K. N., and Lee, J. S. Taraxacum officinale restores inhibition of nitric oxide production by cadmium in mouse peritoneal macrophages. Immunopharmacol.Immunotoxicol. 1998;20(2):283-297.
  • Kim, H. M., Oh, C. H., and Chung, C. K. Activation of inducible nitric oxide synthase by Taraxacum officinale in mouse peritoneal macrophages. Gen.Pharmacol 1999;32(6):683-688.
  • Koo, H. N., Hong, S. H., Song, B. K., Kim, C. H., Yoo, Y. H., and Kim, H. M. Taraxacum officinale induces cytotoxicity through TNF-alpha and IL-1alpha secretion in Hep G2 cells. Life Sci 1-16-2004;74(9):1149-1157.
  • Larsson B, Jonasson A, Fianu S. Prophylactic effect of UVA-E in women with recurrent cystitis: a preliminary report. Curr Ther Res 1993;53:441-3.
  • Liang, K. L., Su, M. C., Shiao, J. Y., Wu, S. H., Li, Y. H., and Jiang, R. S. Role of pollen allergy in Taiwanese patients with allergic rhinitis. J Formos.Med Assoc. 2010;109(12):879-885.
  • Lovell CR, Rowan M. Dandelion dermatitis. Contact Dermatitis 1991;25:185-8.
  • Luo ZH. [The use of Chinese traditional medicines to improve impaired immune functions in scald mice]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 1993;9:56-8, 80.
  • Maliakal PP, Wanwimolruk S. Effect of herbal teas on hepatic drug metabolizing enzymes in rats. J Pharm Pharmacol 2001;53:1323-9.
  • Martín-Muñoz MF, Bartolome B, Caminoa M, et al. Bee pollen: a dangerous food for allergic children. Identification of responsible allergens. Allergol Immunopathol (Madr) 2010;38:263-5.
  • Mascolo N, Autore G, Capassa F, et al. Biological screening of Italian medicinal plants for anti-inflammatory activity. Phytother Res 1987:28-31.
  • Menghini, L., Genovese, S., Epifano, F., Tirillini, B., Ferrante, C., and Leporini, L. Antiproliferative, protective and antioxidant effects of artichoke, dandelion, turmeric and rosemary extracts and their formulation. Int J Immunopathol.Pharmacol 2010;23(2):601-610.
  • Moriarty B, Pinney JH, Owen-Casey MP, Rustin MH, Deroide F, Laing C, Davenport A. Digital necrosis from dandelion tea. Br J Dermatol. 2013 Jul;169(1):227-30.
  • Neef H, Cilli F, Declerck PJ, et al. Platelet anti-aggregating activity of Taraxacum officinale Weber. Phytotherapy Research 1996;10:s138-s140.
  • Onal S, Timur S, Okutucu B, Zihnioglu F. Inhibition of alphaglucosidase by aqueous extracts of some potent antidiabetic medicinal herbs. Prep Biochem Biotechnol 2005;35:29-36.
  • Ovadje, P., Chatterjee, S., Griffin, C., Tran, C., Hamm, C., and Pandey, S. Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J Ethnopharmacol. 1-7-2011;133(1):86-91.
  • Ovadje, P., Chochkeh, M., Akbari-Asl, P., Hamm, C., and Pandey, S. Selective induction of apoptosis and autophagy through treatment with dandelion root extract in human pancreatic cancer cells. Pancreas 2012;41(7):1039-1047.
  • Ovadje, P., Hamm, C., and Pandey, S. Efficient induction of extrinsic cell death by dandelion root extract in human chronic myelomonocytic leukemia (CMML) cells. PLoS.One. 2012;7(2):e30604.
  • Posadzki, P., Watson, L. K., and Ernst, E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med 2013;13(1):7-12.
  • Racz-Kotilla E, Racz G, Solomon A. The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta Med 1974;26:212-7.
  • Rasmussen A, Jacob SE. Dandelion: An important allergen in atopic children. Dermatitis. 2017r;28(2):166.
  • Rodriguez-Fragoso L, Reyes-Esparza J, Burchiel SW, Herrera-Ruiz D, Torres E. Risks and benefits of commonly used herbal medicines in Mexico. Toxicol Appl Pharmacol. 2008 Feb 15;227(1):125-35.
  • Rodriguez, B., Rodriguez, A., de Barrio, M., Tornero, P., and Baeza, M. L. Asthma induced by canary food mix. Allergy Asthma Proc. 2003;24(4):265-268.
  • Seo SW, Koo HN, An HJ, et al. Taraxacum officinale protects against cholecystokinin-induced acute pancreatitis in rats. World J Gastroenterol 2005;11:597-9.
  • Swanston-Flatt, S. K., Day, C., Flatt, P. R., Gould, B. J., and Bailey, C. J. Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res 1989;10(2):69-73.
  • Syhaieva, I. A. [Efficiency of specific immunotherapy in treatment of patients with seasonal allergic rhinitis]. Lik.Sprava. 2006;(1-2):51-53.
  • Tan YM, Wang LH Chen SK. Compound Pugongying decoction for acute suppurative tonsillitis. Journal Of An Hui Zhong YI College 2010;29(4):9-12.
  • Tan YM, Wang LH, Chen SK. Compound Pugongying decoction for acute suppurative tonsillitis. Journal Of An Hui Zhong YI College 2010;29:9-12.
  • Tita B, Bello U, Faccendini P, and et al. Taraxacum officinale W.: pharmacological effect of ethanol extract. Pharmacological Res 1993;27(Suppl 1):23-24.
  • Trojanova I, Rada V, Kokoska L, Vlkova E. The bifidogenic effect of Taraxacum officinale root. Fitoterapia 2004;75:760-3.
  • Wakelin, S. H., Marren, P., Young, E., and Shaw, S. Compositae sensitivity and chronic hand dermatitis in a seven-year-old boy. Br J Dermatol 1997;137(2):289-291.
  • Williams CA, Goldstone F, Greenham J. Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinale. Phytochemistry 1996;42:121-7.
  • Yang, Y., Zhao, Y., Wang, C. S., Wang, X. D., and Zhang, L. [Prevalence of sensitization to aeroallergens in 10 030 patients with allergic rhinitis]. Zhonghua Er.Bi Yan.Hou Tou.Jing.Wai Ke Za Zhi 2011;46(11):914-920.
  • Yousefi Ghale-Salimi M, Eidi M, Ghaemi N, Khavari-Nejad RA. Antiurolithiatic effect of the taraxasterol on ethylene glycol induced kidney calculi in male rats. Urolithiasis. 2018;46(5):419-428.
  • Yousefi Ghale-Salimi M, Eidi M, Ghaemi N, Khavari-Nejad RA. Inhibitory effects of taraxasterol and aqueous extract of Taraxacum officinale on calcium oxalate crystallization: in vitro study. Ren Fail. 2018;40(1):298-305.
  • Zhu M, Wong PY, Li RC. Effects of taraxacum mongolicum on the bioavailability and disposition of ciprofloxacin in rats. J Pharm Sci 1999;88:632-4.

Elderflower

  • Anon. Elderberry (Sambucus species). The Poison Plant Patch, Novia Scotia Museum, 2007. Available at: https://museum.gov.ns.ca/poison/?section=species&id=117 (Accessed 16 October 2009).
  • Chrubasik C, Maier T, Dawid C, et al. An observational study and quantification of the actives in a supplement with Sambucus nigra and Asparagus officinalis used for weight reduction. Phytother Res 2008;22:913-8.
  • Cunha S, Meireles D, Machado J. Sambucus nigra – a promising natural source for human health. Exp Pathol Health Sci. 2016;8(2):59-66.
  • Electronic Code of Federal Regulations. Title 21. Part 182 — Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  • European elder. Canadian Poisonous Plants Information System. Available at: https://www.cbif.gc.ca/pls/pp/ppack.jump?p_null=all&p_psn=121&p_type=all&p_sci=comm&p_x=px (Accessed 16 October 2009).
  • Forster-Waldl E, Marchetti M, Scholl I, Focke M, et al. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clin Exp Allergy 2003;33:1703-10.
  • Gray AM, Abdel-Wahab YH, Flatt PR. The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitro. J Nutr 2000;130:15-20.
  • Marz RW, Ismail C, Popp MA. Action profile and efficacy of a herbal combination preparation for the treatment of sinusitis. Wien Med Wochenschr 1999;149:202-8.
  • Melzer, J., Saller, R., Schapowal, A., and Brignoli, R. Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forsch Komplement.Med (2006.) 2006;13(2):78-87.
  • Mikulic-Petkovsek M, Samoticha J, Eler K, Stampar F, Veberic R. Traditional elderflower beverages: a rich source of phenolic compounds with high antioxidant activity. J Agric Food Chem. 2015;63(5):1477-87.
  • Neubauer N, Marz RW. Placebo-controlled, randomized, double-blind, clincal trial with Sinupret sugar coated tablets on the basis of a therapy with antibiotics and decongestant nasal drops in acute sinusitis. Phytomedicine 1994;1:177-81.
  • Peric A, Kovacevic SV, Gacesa D, Peric AV. Efficacy and safety of combined treatment of acute rhinosinusitis by herbal medicinal product Sinupret and mometasone furoate nasal spray. ENT Updates 2017;7(2):68-74.
  • Picon, P. D., Picon, R. V., Costa, A. F., Sander, G. B., Amaral, K. M., Aboy, A. L., and Henriques, A. T. Randomized clinical trial of a phytotherapic compound containing Pimpinella anisum, Foeniculum vulgare, Sambucus nigra, and Cassia augustifolia for chronic constipation. BMC.Complement Altern.Med. 2010;10:17.
  • Viapiana A, Wesolowski M. The phenolic contents and antioxidant activities of infusions of Sambucus nigra L. Plant Foods Hum Nutr. 2017;72(1):82-7.
  • Vlachojannis JE, Cameron M, Chrubasik S. A systematic review on the sambuci fructus effect and efficacy profiles. Phytother Res. 2010 Jan;24(1):1-8.

Lemongrass

  • Abe, S., Maruyama, N., Hayama, K., Inouye, S., Oshima, H., and Yamaguchi, H. Suppression of neutrophil recruitment in mice by geranium essential oil. Mediators.Inflamm. 2004;13(1):21-24.
  • Abe, S., Sato, Y., Inoue, S., Ishibashi, H., Maruyama, N., Takizawa, T., Oshima, H., and Yamaguchi, H. [Anti-Candida albicans activity of essential oils including Lemongrass (Cymbopogon citratus) oil and its component, citral]. Nippon Ishinkin.Gakkai Zasshi 2003;44(4):285-291.
  • Adeneye, A. A. and Agbaje, E. O. Hypoglycemic and hypolipidemic effects of fresh leaf aqueous extract of Cymbopogon citratus Stapf. in rats. J Ethnopharmacol. 7-25-2007;112(3):440-444.
  • Adukwu EC, Bowles M, Edwards-Jones V, Bone H. Antimicrobial activity, cytotoxicity and chemical analysis of lemongrass essential oil (Cymbopogon flexuosus) and pure citral. Appl Microbiol Biotechnol 2016;100(22):9619-27.
  • Akula S, Nagarathna J, Srinath K. Anti-Plaque and Anti-Gingivitis Efficacy of 0.25% Lemongrass Oil and 0.2% Chlorhexidine Mouthwash in Children. Front Dent 2021;18:32.
  • Avoseh O, Oyedeji O, Rungqu P, Nkeh-Chungag B, Oyedeji A. Cymbopogon species; ethnopharmacology, phytochemistry and the pharmacological importance. Molecules 2015;20(5):7438-53.
  • Blanco, M. M., Costa, C. A., Freire, A. O., Santos, J. G., Jr., and Costa, M. Neurobehavioral effect of essential oil of Cymbopogon citratus in mice. Phytomedicine 2009;16(2-3):265-270.
  • Bleasel, N., Tate, B., and Rademaker, M. Allergic contact dermatitis following exposure to essential oils. Australas.J Dermatol 2002;43(3):211-213.
  • Boukhatem MN, Ferhat MA, Kameli A, Saidi F, Kebir H93T. Lemon grass (Cymbopogon citratus) essential oil as a potent anti-inflammatory and antifungal drugs. Libyan J Med 2014;9:25431.
  • Buckle J. Use of aromatherapy as a complementary treatment for chronic pain. Altern Ther Health Med 1999;5:42-51.
  • Chaisripipat W, Lourith N, Kanlayavattanakul M. Anti-dandruff hair tonic containing lemongrass (Cymbopogon flexuosus) oil. Forsch Komplementmed 2015;22(4):226-9.
  • Cheel, J., Theoduloz, C., Rodriguez, J., and Schmeda-Hirschmann, G. Free radical scavengers and antioxidants from Lemongrass (Cymbopogon citratus (DC.) Stapf.). J Agric.Food Chem 4-6-2005;53(7):2511-2517.
  • Chukwuocha UM, Fernández-Rivera O, Legorreta-Herrera M. Exploring the antimalarial potential of whole Cymbopogon citratus plant therapy. J Ethnopharmacol 2016;193:517-23.
  • Costa CA, Kohn DO, de Lima VM, Gargano AC, Flório JC, Costa M. The GABAergic system contributes to the anxiolytic-like effect of essential oil from Cymbopogon citratus (lemongrass). J Ethnopharmacol 2011;137(1):828-36.
  • Dorman HJ, Deans SG. Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol 2000;88:308-16.
  • Dr. Duke’s Phytochemical and Ethnobotanical Databases. Available at: http://www.ars-grin.gov/duke/.
  • Dudai N, Weinstein Y, Krup M, et al. Citral is a new inducer of caspase-3 in tumor cell lines. Planta Med 2005;71:484-8.
  • Electronic Code of Federal Regulations. Title 21. Part 182 — Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  • Elson, C. E., Underbakke, G. L., Hanson, P., Shrago, E., Wainberg, R. H., and Qureshi, A. A. Impact of lemongrass oil, an essential oil, on serum cholesterol. Lipids 1989;24(8):677-679.
  • Figueirinha, A., Cruz, M. T., Francisco, V., Lopes, M. C., and Batista, M. T. Anti-inflammatory activity of Cymbopogon citratus leaf infusion in lipopolysaccharide-stimulated dendritic cells: contribution of the polyphenols. J Med Food 2010;13(3):681-690.
  • Frosch, P. J., Johansen, J. D., Menne, T., Pirker, C., Rastogi, S. C., Andersen, K. E., Bruze, M., Goossens, A., Lepoittevin, J. P., and White, I. R. Further important sensitizers in patients sensitive to fragrances. Contact Dermatitis 2002;47(5):279-287.
  • Halabi MF, Sheikh BY. Anti-proliferative effect and phytochemical analysis of Cymbopogon citratus extract. Biomed Res Int 2014;2014:906239.
  • Kimutai A, Ngeiywa M, Mulaa M, et al. Repellent effects of the essential oils of Cymbopogon citratus and Tagetes minuta on the sandfly, Phlebotomus duboscqi. BMC Res Notes 2017;10(1):98.
  • Lalko, J. and Api, A. M. Investigation of the dermal sensitization potential of various essential oils in the local lymph node assay. Food Chem Toxicol 2006;44(5):739-746.
  • Lee, H. J., Jeong, H. S., Kim, D. J., Noh, Y. H., Yuk, D. Y., and Hong, J. T. Inhibitory effect of citral on NO production by suppression of iNOS expression and NF-kappa B activation in RAW264.7 cells. Arch Pharm.Res 2008;31(3):342-349.
  • Leite JR, Seabra Mde L, Maluf E, et al. Pharmacology of lemongrass (Cymbopogon citratus Stapf). III. Assessment of eventual toxic, hypnotic and anxiolytic effects on humans. J Ethnopharmacol 1986;17:75-83.
  • Li CC, Yu HF, Chang CH, Liu YT, Yao HT. Effects of lemongrass oil and citral on hepatic drug-metabolizing enzymes, oxidative stress, and acetaminophen toxicity in rats. J Food Drug Anal 2018;26(1):432-8.
  • Lorenzetti, B. B., Souza, G. E., Sarti, S. J., Santos, Filho D., and Ferreira, S. H. Myrcene mimics the peripheral analgesic activity of lemongrass tea. J Ethnopharmacol 1991;34(1):43-48.
  • Manikandan S, Bhambal AM, Ratchambiga KS, Nithiela M, Swatheka JK, Sridarshini B. Comparative Evaluation of the Effect of 0.2% Chlorhexidine, 2% LemonGrass Oil, and 2% Tea Tree Oil Mouth rinse on Salivary pH: An In vivo Study. J Pharm Bioallied Sci 2021;13(Suppl 1):S757-S760.
  • Meenapriya M, Priya J. Effect of lemongrass oil on rheumatoid arthritis. J Pharm Sci Res 2017;9(2):237-9.
  • Nakamura, Y., Miyamoto, M., Murakami, A., Ohigashi, H., Osawa, T., and Uchida, K. A phase II detoxification enzyme inducer from lemongrass: identification of citral and involvement of electrophilic reaction in the enzyme induction. Biochem Biophys Res Commun. 3-14-2003;302(3):593-600.
  • Ohno, T., Kita, M., Yamaoka, Y., Imamura, S., Yamamoto, T., Mitsufuji, S., Kodama, T., Kashima, K., and Imanishi, J. Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter. 2003;8(3):207-215.
  • Oliveira, V. C., Moura, D. M., Lopes, J. A., de Andrade, P. P., da Silva, N. H., and Figueiredo, R. C. Effects of essential oils from Cymbopogon citratus (DC) Stapf., Lippia sidoides Cham., and Ocimum gratissimum L. on growth and ultrastructure of Leishmania chagasi promastigotes. Parasitol.Res 2009;104(5):1053-1059.
  • Pereira, R. P., Fachinetto, R., de Souza, Prestes A., Puntel, R. L., Santos da Silva, G. N., Heinzmann, B. M., Boschetti, T. K., Athayde, M. L., Burger, M. E., Morel, A. F., Morsch, V. M., and Rocha, J. B. Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. Neurochem.Res. 2009;34(5):973-983.
  • Pushpanathan, T., Jebanesan, A., and Govindarajan, M. Larvicidal, ovicidal and repellent activities of Cymbopogan citratus Stapf (Graminae) essential oil against the filarial mosquito Culex quinquefasciatus (Say) (Diptera : Culicidae). Trop.Biomed. 2006;23(2):208-212.
  • Rao, V. S., Menezes, A. M., and Viana, G. S. Effect of myrcene on nociception in mice. J Pharm Pharmacol 1990;42(12):877-878.
  • Santin, M. R., dos Santos, A. O., Nakamura, C. V., Dias Filho, B. P., Ferreira, I. C., and Ueda-Nakamura, T. In vitro activity of the essential oil of Cymbopogon citratus and its major component (citral) on Leishmania amazonensis. Parasitol.Res 2009;105(6):1489-1496.
  • Santoro, G. F., Cardoso, M. G., Guimaraes, L. G., Freire, J. M., and Soares, M. J. Anti-proliferative effect of the essential oil of Cymbopogon citratus (DC) Stapf (lemongrass) on intracellular amastigotes, bloodstream trypomastigotes and culture epimastigotes of Trypanosoma cruzi (Protozoa: Kinetoplastida). Parasitology 2007;134(Pt 11):1649-1656.
  • Sforcin, J. M., Amaral, J. T., Fernandes, A., Jr., Sousa, J. P., and Bastos, J. K. Lemongrass effects on IL-1beta and IL-6 production by macrophages. Nat.Prod.Res 2009;23(12):1151-1159.
  • Shah G, Shri R, Panchal V, Sharma N, Singh B, Mann AS. Scientific basis for the therapeutic use of Cymbopogon citratus, stapf (Lemon grass). J Adv Pharm Technol Res 2011;2(1):3-8.
  • Silva, M. R., Ximenes, R. M., da Costa, J. G., Leal, L. K., de Lopes, A. A., and Viana, G. S. Comparative anticonvulsant activities of the essential oils (EOs) from Cymbopogon winterianus Jowitt and Cymbopogon citratus (DC) Stapf. in mice. Naunyn Schmiedebergs Arch Pharmacol 2010;381(5):415-426.
  • Soonwera M, Phasomkusolsil S. Effect of Cymbopogon citratus (lemongrass) and Syzygium aromaticum (clove) oils on the morphology and mortality of Aedes aegypti and Anopheles dirus larvae. Parasitol Res 2016;115(4):1691-703.
  • Tapia, A., Cheel, J., Theoduloz, C., Rodriguez, J., Schmeda-Hirschmann, G., Gerth, A., Wilken, D., Jordan, M., Jimenez-Gonzalez, E., Gomez-Kosky, R., and Mendoza, E. Q. Free radical scavengers from Cymbopogon citratus (DC.) stapf plants cultivated in bioreactors by the temporary immersion (TIS) principle. Z.Naturforsch.C 2007;62(5-6):447-457.
  • Tchoumbougnang, F., Zollo, P. H., Dagne, E., and Mekonnen, Y. In vivo antimalarial activity of essential oils from Cymbopogon citratus and Ocimum gratissimum on mice infected with Plasmodium berghei. Planta Med 2005;71(1):20-23.
  • Trongtokit, Y., Rongsriyam, Y., Komalamisra, N., and Apiwathnasorn, C. Comparative repellency of 38 essential oils against mosquito bites. Phytother Res 2005;19(4):303-309.
  • Viana, G. S., Vale, T. G., Pinho, R. S., and Matos, F. J. Antinociceptive effect of the essential oil from Cymbopogon citratus in mice. J Ethnopharmacol 2000;70(3):323-327.
  • Wohrl, S., Hemmer, W., Focke, M., Gotz, M., and Jarisch, R. The significance of fragrance mix, balsam of Peru, colophony and propolis as screening tools in the detection of fragrance allergy. Br.J Dermatol. 2001;145(2):268-273.
  • Wright, S. C., Maree, J. E., and Sibanyoni, M. Treatment of oral thrush in HIV/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet. Phytomedicine 2009;16(2-3):118-124.

Milk Thistle

  • Aboras SI, Korany MA, El-Yazbi AF, Ragab MAA, Abdine HH. In-depth investigation of the Silymarin effect on the pharmacokinetic parameters of sofosbuvir, GS-331007 and ledipasvir in rat plasma using LC-MS. Biomed Chromatogr 2022;36(9):e5427.
  • Adverse Drug Reactions Advisory Committee. An adverse reaction to the herbal medication milk thistle (Silybum marianum). Med J Aust 1999;170:218-9.
  • Ahmed S, Ullah N, Parveen S, et al. Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial. Oxid Med Cell Longev 2022;2022:9199190.
  • Allain, H., Schuck, S., Lebreton, S., Strenge-Hesse, A., Braun, W., Gandon, J. M., and Brissot, P. Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer’s disease. Dement.Geriatr.Cogn Disord. 1999;10(3):181-185.
  • Aller R, Izaola O, Gómez S, et al. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study. Eur Rev Med Pharmacol Sci. 2015;19(16):3118-24.
  • Angulo, P., Patel, T., Jorgensen, R. A., Therneau, T. M., and Lindor, K. D. Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology 2000;32(5):897-900.
  • Anon. Adverse reaction: milk thistle-associated toxicity. Nurse Drug Alert 1999;23(7):51.
  • Anon. Milk thistle: Effects on liver disease and cirrhosis and clinical adverse effects. Summary, Evidence Report/Technology Assessment: Number 21, September 2000. Agency for Healthcare Research and Quality, Rockville, MD. Available at: https://www.ahrq.gov/clinic/epcsums/milktsum.htm
  • Aryan H, Farahani RH, Chamanara M, et al. Evaluation of the efficacy of oral nano-silymarin formulation in hospitalized patients with COVID-19: A double-blind placebo-controlled clinical trial. Phytother Res 2022;36(10):3924-3931.
  • Asghar, Z. and Masood, Z. Evaluation of antioxidant properties of silymarin and its potential to inhibit peroxyl radicals in vitro. Pak.J Pharm Sci 2008;21(3):249-254.
  • Atarodi H, Pazouki A, Gholizadeh B, et al. Effect of silymarin on liver size and nonalcoholic fatty liver disease in morbidly obese patients: A randomized double-blind clinical trial. J Res Med Sci 2022;27:76.
  • Bageorgou F, Li L, Beausillon C, Stennevin A, Ortiz-Brugués A, Saurat JH. Tolerability and effectiveness of a dermocosmetic product containing Silybum marianum fruit extract in adolescents and young adults with acne-prone skin: An international, phase IV, longitudinal study. J Cosmet Dermatol 2023.
  • Bakhshaee M, Jabbari F, Hoseini S, et al. Effect of silymarin in the treatment of allergic rhinitis. Otolaryngology – Head and Neck Surgery 2011;145:904-9.
  • Barbosa CC, Nishimura AN, Santos MLD, et al. Silymarin administration during pregnancy and breastfeeding: evaluation of initial development and adult behavior of mice. Neurotoxicology 2020;78:64-70.
  • Barzaghi, N., Crema, F., Gatti, G., Pifferi, G., and Perucca, E. Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet. 1990;15(4):333-338.
  • Basaga, H., Poli, G., Tekkaya, C., and Aras, I. Free radical scavenging and antioxidative properties of ‘silibin’ complexes on microsomal lipid peroxidation. Cell Biochem Funct. 1997;15(1):27-33.
  • Batakov, E. A. [Effect of Silybum marianum oil and legalon on lipid peroxidation and liver antioxidant systems in rats intoxicated with carbon tetrachloride]. Eksp.Klin Farmakol. 2001;64(4):53-55.
  • Bean, P. The use of alternative medicine in the treatment of hepatitis C. Am.Clin.Lab 2002;21(4):19-21.
  • Becker-Schiebe, M., Mengs, U., Schaefer, M., Bulitta, M., and Hoffmann, W. Topical use of a silymarin-based preparation to prevent radiodermatitis : results of a prospective study in breast cancer patients. Strahlenther.Onkol. 2011;187(8):485-491.
  • Beckmann-Knopp S, Rietbrock S, Weyhenmeyer R, et al. Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes. Pharmacol Toxicol 2000;86:250-6.
  • Benda, L., Dittrich, H., Ferenzi, P., Frank, H., and Wewalka, F. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis]. Wien.Klin.Wochenschr. 10-10-1980;92(19):678-683.
  • Bhatia, N. and Agarwal, R. Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells. Prostate 2-1-2001;46(2):98-107.
  • Boari, C., Montanari, F. M., Galletti, G. P., Rizzoli, D., Baldi, E., Caudarella, R., and Gennari, P. [Toxic occupational liver diseases. Therapeutic effects of silymarin]. Minerva Med 10-20-1981;72(40):2679-2688.
  • Bode, J. C., Schmidt, U., and Durr, H. K. [Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author’s transl)]. Med Klin. 3-25-1977;72(12):513-518.
  • Boerth J, Strong KM. The clinical utility of milk thistle (Silybum marianum) in cirrhosis of the liver. J Herb Pharmacother 2002;2:11-7.
  • Bokemeyer, C., Fels, L. M., Dunn, T., Voigt, W., Gaedeke, J., Schmoll, H. J., Stolte, H., and Lentzen, H. Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity. Br J Cancer 1996;74(12):2036-2041.v
  • Brinda, B. J., Zhu, H. J., and Markowitz, J. S. A sensitive LC-MS/MS assay for the simultaneous analysis of the major active components of silymarin in human plasma. J.Chromatogr.B Analyt.Technol.Biomed.Life Sci. 8-1-2012;902:1-9.
  • Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000;7:273-82.
  • Budzinski JW, Trudeau VL, Drouin CE, et al. Modulation of human cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) in Caco-2 cell monolayers by selected commercial-source milk thistle and goldenseal products. Can J Physiol Pharmacol 2007;85:966-78.
  • Bunout D, Hirsch S, Petermann M. [Controlled study of the effect of silymarin on alcoholic liver disease.] Rev Med Chil 1992;120:1370-5.
  • Buzzelli G, Moscarella S, Giusti A, et al. A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis. Int J Clin Pharmacol Ther Toxicol 1993;31:456-60.
  • Carducci, R., Armellino, M. F., Volpe, C., Basile, G., Caso, N., Apicella, A., and Basile, V. [Silibinin and acute poisoning with Amanita phalloides]. Minerva Anestesiol. 1996;62(5):187-193.
  • Carini, R., Comoglio, A., Albano, E., and Poli, G. Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phospholipid complex IdB 1016. Biochem Pharmacol 5-28-1992;43(10):2111-2115.
  • Cavalieri S. A controlled clinical trial of Legalon in 40 patients. Gazz Med Ital 1974;133:628-635.
  • Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-23.
  • Chevallier A. Encyclopedia of Herbal Medicine. 2nd ed. New York, NY: DK Publ, Inc., 2000.
  • Comoglio, A., Tomasi, A., Malandrino, S., Poli, G., and Albano, E. Scavenging effect of silipide, a new silybin-phospholipid complex, on ethanol-derived free radicals. Biochem.Pharmacol 10-12-1995;50(8):1313-1316.
  • Cossiga V, Sanduzzi-Zamparelli M, Sapena V, et al. Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study. Front Pharmacol 2022;13:824879.
  • Darvishi-Khezri H, Naderisorki M, Zahedi M, et al. Coadministration of silymarin with iron chelators in transfusion-dependent ß-thalassemia patients: a systematic review and meta-analysis for effect on iron overload. Expert Rev Clin Pharmacol. 2021;14(11):1445-53.
  • de Font-Reaulx, Rojas E. and Dorazco-Barragan, G. [Clinical stabilisation in neurodegenerative diseases: clinical study in phase II]. Rev.Neurol. 5-1-2010;50(9):520-528.
  • Dehmlow, C., Murawski, N., and de Groot, H. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sci 1996;58(18):1591-1600.
  • Deng JW, Shon JH, Shin HJ, et al. Effect of silymarin supplement on the pharmacokinetics of rosuvastatin. Pharm Res 2008;25:1807-14.
  • Derosa G, D’Angelo A, Maffioli P. The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus. Clin Nutr. 2016;35(5):1091-5.
  • Derosa G, D’Angelo A, Romano D, Maffioli P. Effects of a combination of Berberis aristata, Silybum marianum and monacolin on lipid profile in subjects at low cardiovascular risk; A double-blind, randomized, placebo-controlled trial. Int J Mol Sci. 2017;18(2). pii: E343.
  • Derosa G, Romano D, D’Angelo A, Maffioli P. Berberis aristata/Silybum marianum fixed combination (Berberol(®)) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: a randomized, placebo-controlled, clinical trial. Phytomedicine. 2015;22(2):231-7.
  • Detaille, D., Sanchez, C., Sanz, N., Lopez-Novoa, J. M., Leverve, X., and El Mir, M. Y. Interrelation between the inhibition of glycolytic flux by silibinin and the lowering of mitochondrial ROS production in perifused rat hepatocytes. Life Sci 5-23-2008;82(21-22):1070-1076.
  • Di Pierro F, Bellone I, Rapacioli G, Putignano P. Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins. Diabetes Metab Syndr Obes. 2015;8:89-96.
  • Di Pierro F, Villanova N, Agostini F, Marzocchi R, Soverini V, Marchesini G. Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control. Diabetes Metab Syndr Obes. 2012;5:213-7.
  • DiCenzo R, Shelton M, Jordan K, et al. Coadministration of milk thistle and indinavir in healthy subjects. Pharmacotherapy 2003;23:866-70.
  • Doehmer J, Weiss G, McGregor GP, Appel K. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities. Toxicol In Vitro 2011;25:21-7.
  • Eagon PK, Elm MS, Hunter DS, et al. Medicinal herbs: modulation of estrogen action. Era of Hope Mtg, Dept Defense; Breast Cancer Res Prog, Atlanta, GA 2000;Jun 8-11.
  • Ebrahimpour-Koujan S, Gargari BP, Mobasseri M, Valizadeh H, Asghari-Jafarabadi M. Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial. Phytomedicine. 2018;44:39-44.
  • El-Kamary, S. S., Shardell, M. D., Abdel-Hamid, M., Ismail, S., El-Ateek, M., Metwally, M., Mikhail, N., Hashem, M., Mousa, A., Aboul-Fotouh, A., El-Kassas, M., Esmat, G., and Strickland, G. T. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Phytomedicine. 2009;16(5):391-400.
  • El-Shitany NA, Hegazy S, El-Desoky K. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats. Phytomedicine. 2010;17(2):116-25.
  • Elyasi S, Hosseini S, Niazi Moghadam MR, Aledavood SA, Karimi G. Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytother Res. 2016;30(11):1879-85.
  • Elyasi S, Shojaee FSR, Allahyari A, Karimi G. Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytother Res. 2017;31(9):1323-29.
  • Eurich, D., Bahra, M., Berg, T., Boas-Knoop, S., Biermer, M., Neuhaus, R., Neuhaus, P., and Neumann, U. Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy. Exp.Clin.Transplant. 2011;9(1):1-6.
  • Fallah Huseini, H., Larijani, B., Fakhrzadeh, H., Rajabi Pour, B., Akhondzadeh, S., Toliat, T., and Heshmat, R. The clinical trial of Silybum Marianum seed extract (Silymarin) on type II diabetic patients with hyperlipidemia. Iran J.Diabetes Lipid Disord. 2004;3(2):201-206.
  • Fallahzadeh, M. K., Dormanesh, B., Sagheb, M. M., Roozbeh, J., Vessal, G., Pakfetrat, M., Daneshbod, Y., Kamali-Sarvestani, E., and Lankarani, K. B. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial. Am.J.Kidney Dis. 2012;60(6):896-903.
  • Feher J, Deak G, Muzes G, et al. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases]. Orv Hetil 1989;130:2723-7.
  • Feher, J., Lang, I., Nekam, K., Muzes, G., and Deak, G. Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis. Acta Med Hung. 1988;45(3-4):265-276.
  • Fenclova M, Novakova A, Viktorova J, et al. Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes. Sci Rep. 2019;9(1):11118.
  • Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol 1989;9:105-13.
  • Fintelmann V. Zur Therapie der Fettleber mit Silymarin. Therapiewoche 1970;20:1055-2064.
  • Flaig, T. W., Glode, M., Gustafson, D., van, Bokhoven A., Tao, Y., Wilson, S., Su, L. J., Li, Y., Harrison, G., Agarwal, R., Crawford, E. D., Lucia, M. S., and Pollak, M. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer. Prostate 6-1-2010;70(8):848-855.
  • Flora K, Hahn M, Rosen H, Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998;93:139-43.
  • Flory, P. J., Krug, G., Lorenz, D., and Mennicke, W. H. [Studies on elimination of silymarin in cholecystectomized patients. I. Biliary and renal elimination after a single oral dose]. Planta Med 1980;38(3):227-237.
  • Foster S, Tyler VE. Tyler’s Honest Herbal, 4th ed., Binghamton, NY: Haworth Herbal Press, 1999.
  • Freedman ND, Curto TM, Morishima C, et al. Silymarin use and liver disease progression in the hepatitis C Antiviral Long-Term Treatment against Cirrhosis Trial. Aliment Pharmacol Ther 2011;33:127-37.
  • Frerick F, Kuhn U, and Strenge-Hesse A. Silymarin–ein Phytopharmakon zur Behandlung toxischen Leberschaden: Anwendungsbeobachtung bei 2169 Patienten. Kassenarzt 1990;33:36-41.
  • Fried, M. W., Navarro, V. J., Afdhal, N., Belle, S. H., Wahed, A. S., Hawke, R. L., Doo, E., Meyers, C. M., and Reddy, K. R. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA 7-18-2012;308(3):274-282.
  • Gaedeke, J., Fels, L. M., Bokemeyer, C., Mengs, U., Stolte, H., and Lentzen, H. Cisplatin nephrotoxicity and protection by silibinin. Nephrol.Dial.Transplant. 1996;11(1):55-62.
  • Gamissans M, Expósito-Serrano V, López-Llunell C, Valdivieso L, Garbayo-Salmons P. Bullous pemphigoid triggered by Silybum marianum: an unexpected side effect of an herbal remedy. Int J Dermatol. 2021 Aug 7. doi: 10.1111/ijd.15822.
  • Gatti, G. and Perucca, E. Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers. Int.J Clin Pharmacol.Ther. 1994;32(11):614-617.
  • Gharagozloo, M., Moayedi, B., Zakerinia, M., Hamidi, M., Karimi, M., Maracy, M., and Amirghofran, Z. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial. Fundam.Clin.Pharmacol. 2009;23(3):359-365.
  • Ghiasian M, Nafisi H, Ranjbar A, Mohammadi Y, Ataei S. Antioxidative effects of silymarin on the reduction of liver complications of fingolimod in patients with relapsing-remitting multiple sclerosis: a clinical trial study. J Biochem Mol Toxicol 2021.
  • Giorgi, V. S., Peracoli, M. T., Peracoli, J. C., Witkin, S. S., and Bannwart-Castro, C. F. Silibinin modulates the NF-kappab pathway and pro-inflammatory cytokine production by mononuclear cells from preeclamptic women. J.Reprod.Immunol. 2012;95(1-2):67-72.
  • Grant JE and Odlaug BL. Silymarin treatment of obsessive-compulsive spectrum disorders. J Clin Psychopharmacol. 2015;35(3):340-2.
  • Grant JE, Redden SA, Chamberlain SR. Milk Thistle Treatment for Children and Adults with Trichotillomania: A Double-Blind, Placebo-Controlled, Crossover Negative Study. J Clin Psychopharmacol 2019;39(2):129-34. doi: 10.1097/JCP.0000000000001005.
  • Grungreiff K, Albrecht M, and Strenge-Hesse A. Benefit of medicinal liver therapy in general practice. Med Welt 1995;46:222-227.
  • Guarino G, Strollo F, Carbone L, et al. Bioimpedance analysis, metabolic effects and safety of the association Berberis aristata/Bilybum marianum: a 52-week double-blind, placebo-controlled study in obese patients with type 2 diabetes. J Biol Regul Homeost Agents. 2017;31(2):495-502.
  • Gufford BT, Chen G, Vergara AG, et al. Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug Interaction. Drug Metab Dispos. 2015;43(9):1353-9.
  • Gurley B, Hubbard MA, Williams DK, et al. Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin. J Clin Pharmacol 2006;46:201-13.
  • Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 2004;76:428-40.
  • Gurley, B. J., Barone, G. W., Williams, D. K., Carrier, J., Breen, P., Yates, C. R., Song, P. F., Hubbard, M. A., Tong, Y., and Cheboyina, S. Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos. 2006;34(1):69-74.
  • Hasani-Ranjbar, S., Larijani, B., and Abdollahi, M. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm.Allergy Drug Targets. 2009;8(1):2-10.
  • Hasani-Ranjbar, S., Nayebi, N., Moradi, L., Mehri, A., Larijani, B., and Abdollahi, M. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review. Curr.Pharm.Des 2010;16(26):2935-2947.
  • Hawke, R. L., Schrieber, S. J., Soule, T. A., Wen, Z., Smith, P. C., Reddy, K. R., Wahed, A. S., Belle, S. H., Afdhal, N. H., Navarro, V. J., Berman, J., Liu, Q. Y., Doo, E., and Fried, M. W. Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C. J.Clin.Pharmacol. 2010;50(4):434-449.
  • Hikino, H., Kiso, Y., Wagner, H., and Fiebig, M. Antihepatotoxic actions of flavonolignans from Silybum marianum fruits. Planta Med 1984;50(3):248-250.
  • Holtmann G, Madisch A, Juergen H, et al. A double-blind, randomized, placebo-controlled trial on the effects of an herbal preparation in patients with functional dyspepsia [Abstract]. Ann Mtg Digestive Disease Week 1999 May.
  • Hruby K, Csomos G, Fuhrmann M, Thaler H. Chemotherapy of Amanita phalloides poisoning with intravenous silibinin. Hum Toxicol 1983;2:183-95.
  • Huseini HF, Larijani B, Heshmat R, et al. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 2006;20;1036-9.
  • Hussain, S. A. Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes. J.Med.Food 2007;10(3):543-547.
  • Iakimchuk, G. N. and Gendrikson, L. N. [Study of clinical efficiency of essential phospholipids and silymarin combination in nonalcoholic and alcoholic steatohepatitis]. Eksp.Klin.Gastroenterol. 2011;(7):64-69.
  • Ibrahim SMA, Farag AS, Ali MS, El-Gendy WMAF. Efficacy and safety of topical silymarin versus low fluence 1064-nm Q switched Nd:YAG laser in the treatment of melasma: a comparative randomized trial. Lasers Surg Med 2021.
  • Jacobs, B. P., Dennehy, C., Ramirez, G., Sapp, J., and Lawrence, V. A. Milk thistle for the treatment of liver disease: a systematic review and meta-analysis. Am J Med 10-15-2002;113(6):506-515.
  • Jalloh MA, Gregory PJ, Hein D, et al. Dietary supplement interactions with antiretrovirals: a systematic review. Int J STD AIDS. 2017 Jan;28(1):4-15.
  • Jamalian M, Mahmodiyeh B, Saveiee S, Solhi H. Investigating the impact of silymarin on liver oxidative injury. J Family Med Prim Care. 2020;9(3):1707-11.
  • Jiao Z, Shi XJ, Li ZD, et al. Population pharmacokinetics of sirolimus in de novo Chinese adult renal transplant patients. Br.J.Clin.Pharmacol. 2009;68(1):47-60.
  • Jowkar F, Godarzi H, Parvizi MM. Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral Silybum marianum product versus phototherapy alone. J Dermatolog Treat. 2020;31(3):256-60.
  • Kalopitas G, Antza C, Doundoulakis I, et al. Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis. Nutrition. 2021;83:111092.
  • Katiyar, S. K., Korman, N. J., Mukhtar, H., and Agarwal, R. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl.Cancer Inst. 4-16-1997;89(8):556-566.
  • Kawaguchi-Suzuki M, Frye RF, Zhu HJ, et al. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity. Drug Metab Dispos. 2014;42(10):1611-6.
  • Kiesewetter, E., Leodolter, I., and Thaler, H. [Results of two double-blind studies on the effect of silymarine in chronic hepatitis (author’s transl)]. Leber Magen Darm 1977;7(5):318-323.
  • Kim CS, Choi SJ, Park CY, et al. Effects of silybinin on the pharmacokinetics of tamoxifen and its active metabolite, 4-hydroxytamoxifen in rats. Anticancer Res 2010;30:79-85.
  • Kim DH, Jin YH, Park JB, Kobashi K. Silymarin and its components are inhibitors of beta-glucuronidase. Biol Pharm Bull 1994;17:443-5.
  • Kim J, Lee YN, Lee J, et al. Efficacy and safety of silymarin containing antioxidant serum as an adjuvant treatment of mild-to-moderate acne vulgaris: A prospective, open-label pilot study. J Cosmet Dermatol 2023;22(2):561-568.
  • Kittur, S., Wilasrusmee, S., Pedersen, W. A., Mattson, M. P., Straube-West, K., Wilasrusmee, C., Lubelt, B., and Kittur, D. S. Neurotrophic and neuroprotective effects of milk thistle (Silybum marianum) on neurons in culture. J Mol.Neurosci. 2002;18(3):265-269.
  • Kohutek F, Bystricky B. Optimal dose of silymarin for the management of drug induced liver injury in oncology. Mol Clin Oncol 2023;18(5):35.
  • Kuo YJ, Chang HP, Chang YJ, Wu HH, Chen CH. Evaluation of nephroprotection of silymarin on contrast-induced nephropathy in liver cirrhosis patients: A population-based cohort study. Medicine (Baltimore) 2018;97(37):e12243.
  • Ladas, E. J., Kroll, D. J., Oberlies, N. H., Cheng, B., Ndao, D. H., Rheingold, S. R., and Kelly, K. M. A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer 1-15-2010;116(2):506-513.
  • Lahiri-Chatterjee, M., Katiyar, S. K., Mohan, R. R., and Agarwal, R. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Res 2-1-1999;59(3):622-632.
  • Lang, I., Deak, G., Nekam, K., Muzes, G., Gonzalez-Cabello, R., Gergely, P., and Feher, J. Hepatoprotective and immunomodulatory effects of antioxidant therapy. Acta Med Hung. 1988;45(3-4):287-295.
  • Lash DB, Ward S. CYP2C9-mediated warfarin and milk thistle interaction. J Clin Pharm Ther. 2019.
  • Lee JI, Narayan M, Barrett JS. Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007;845(1):95-103.
  • Li, J., Lin, W. F., Pan, Y. Y., and Zhu, X. Y. [Protective effect of silibinin on liver injury induced by antituberculosis drugs]. Zhonghua Gan Zang.Bing.Za Zhi. 2010;18(5):385-386.
  • Lirussi F, Nassuato G, Orlando R, and et al. Treatment of active cirrhosis with ursodeoxycholic acid and a free radical scavenger: A two year prospective study. Med Sci Ress 1995;23:31-33.
  • Locher, R., Suter, P. M., Weyhenmeyer, R., and Vetter, W. Inhibitory action of silibinin on low density lipoprotein oxidation. Arzneimittelforschung. 1998;48(3):236-239.
  • Loguercio C, Andreone P, Brisc C, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med 2012;52(9):1658-65.
  • Luangchosiri C, Thakkinstian A, Chitphuk S, Stitchantrakul W, Petraksa S, Sobhonslidsuk A. A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. BMC Complement Altern Med. 2015;15:334.
  • Lucena, M. I., Andrade, R. J., de la Cruz, J. P., Rodriguez-Mendizabal, M., Blanco, E., and Sanchez, de la Cuesta. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo- controlled clinical study. Int J Clin Pharmacol Ther 2002;40(1):2-8.
  • Madisch A, Holtmann G, Mayr G, et al. Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial. Digestion 2004;69:45-52.
  • Madisch A, Melderis H, Mayr G, et al. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study]. Z Gastroenterol 2001;39(7):511-7.
  • Magdalan, J., Piotrowska, A., Gomulkiewicz, A., Sozanski, T., Szelag, A., and Dziegiel, P. Influence of commonly used clinical antidotes on antioxidant systems in human hepatocyte culture intoxicated with alpha-amanitin. Hum.Exp.Toxicol. 2011;30(1):38-43.
  • Magliulo, E., Gagliardi, B., and Fiori, G. P. [Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres (author’s transl)]. Med Klin. 7-14-1978;73(28-29):1060-1065.
  • Maitrejean M, Comte G, Barron D, et al. The flavanolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of P-glycoprotein. Bioorg Med Chem Lett 2000;10:157-60.
  • Malekshah RE, Khaleghian A. Influence of Silybum marianum on morphine addicted rats, biochemical parameters and molecular simulation studies on µ-opioid receptor. Drug Res (Stuttg). 2019;69(11):630-638.
  • Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. J Immunol 1999;163:6800-9.
  • Marcelli R, Bizzoni P, Conte D, and et al. Randomized controlled study of the efficacy and tolerability of a short course of IdB 1016 in the treatment of chronic persistent hepatitis. Eur Bull Drug Res 1992;1(3):131-135.
  • Marena C and Lampertico M. Preliminary clinical development of silipide: a new complex of silybin in toxic liver disorders. Planta Med 1991;57(2):A124-A125.
  • Melzer J, Rosch W, Reichling J, et al. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther 2004;20:1279-87.
  • Mereish, K. A., Bunner, D. L., Ragland, D. R., and Creasia, D. A. Protection against microcystin-LR-induced hepatotoxicity by Silymarin: biochemistry, histopathology, and lethality. Pharm.Res 1991;8(2):273-277.
  • Mira ML, Azevedo MS, and Manso C. The neutralization of hydroxyl radical by silibin, sorbinil and bendazac. Free Radical Res Commun 1987;4(125):129.
  • Mirhashemi SH, Hakakzadeh A, Yeganeh FE, Oshidari B, Rezaee SP. Effect of 8 Weeks milk thistle powder (silymarin extract) supplementation on fatty liver disease in patients candidates for bariatric surgery. Metabol Open 2022;14:100190.
  • Mirnezami M, Jafarimanesh H, Rezagholizamenjany M, et al. The effect of silymarin on liver enzymes in patients taking isotretinoin: a randomized clinical trial. Dermatol Ther. 2020:33(2):e13236.
  • Mironets VI, Krasovskaia EA, and Polishchuk II. [A case of urticaria during Carsil treatment]. Vrach Delo 1990;7:86-87.
  • Mirzaei E, Sabetian G, Masjedi M, et al. The effect of silymarin on liver enzymes and antioxidant status in trauma patients in the intensive care unit: a randomized double blinded placebo-controlled clinical trial. Clin Exp Hepatol 2021;7(2):149-155.
  • Mirzaei N, Jahanian Sadatmahalleh S, Rouholamin S, Nasiri M. A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations. Sci Rep 2022;12(1):17549.
  • Moayedi B, Gharagozloo M, Esmaeil N, et al. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine. Eur J Haematol 2013;90(3):202-9.
  • Moezian GSA, Javadinia SA, Sales SS, Fanipakdel A, Elyasi S, Karimi G. Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: a randomized, triple blind, placebo-controlled clinical trial. J Oncol Pharm Pract 2021.
  • Moosavifar, N., Mohammadpour, A. H., Jallali, M., Karimiz, G., and Saberi, H. Evaluation of effect of silymarin on granulosa cell apoptosis and follicular development in patients undergoing in vitro fertilization. East Mediterr.Health J. 2010;16(6):642-645.
  • Nassuato, G., Iemmolo, R. M., Strazzabosco, M., Lirussi, F., Deana, R., Francesconi, M. A., Muraca, M., Passera, D., Fragasso, A., Orlando, R., and . Effect of Silibinin on biliary lipid composition. Experimental and clinical study. J Hepatol. 1991;12(3):290-295.
  • Navarro VJ, Belle SH, D’Amato M, et al. Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial. PLoS One. 2019;14(9):e0221683.
  • Pade, D. and Stavchansky, S. Selection of bioavailability markers for herbal extracts based on in silico descriptors and their correlation to in vitro permeability. Mol.Pharm. 2008;5(4):665-671.
  • Palasciano G, Portincasa P, Palmieri V, and et al. The effect of silymarin on plasma levels of malon-dialdehyde in patients receiving long-term treatment with psychotropic drugs. Current Therapeutic Research 1994;55(5):537-545.
  • Par, A., Roth, E., Miseta, A., Hegedus, G., Par, G., Hunyady, B., and Vincze, A. [Effects of supplementation with the antioxidant flavonoid, silymarin, in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study]. Orv.Hetil. 1-11-2009;150(2):73-79.
  • Pares A, Planas R, Torres M, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol 1998;28:615-21.
  • Payer, B. A., Reiberger, T., Rutter, K., Beinhardt, S., Staettermayer, A. F., Peck-Radosavljevic, M., and Ferenci, P. Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient. J.Clin.Virol. 2010;49(2):131-133.
  • Peila C, Coscia A, Tonetto P, et al. Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks). Pediatr Med Chir. 2015;37(3):105.
  • Piscitelli SC, Formentini E, Burstein AH, et al. Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers. Pharmacotherapy 2002;22:551-6.
  • Rambaldi, A., Jacobs, B. P., and Gluud, C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane.Database.Syst.Rev 2007;(4):CD003620.
  • Ramellini, G. and Meldolesi, J. Liver protection by silymarin: in vitro effect on dissociated rat hepatocytes. Arzneimittelforschung. 1976;26(1):69-73.
  • Ramirez-Santos, A., Perez-Bustillo, A., Gonzalez-Sixto, B., Suarez-Amor, O., and Rodriguez-Prieto, M. A. [Acute generalized exanthematous pustulosis due to milk thistle (Silybum marianum) tea]. Actas Dermosifiliogr. 2011;102(9):744-745.
  • Rastegarpanah M, Malekzadeh R, Vahedi H, et al. A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis. Chin J Integr Med. 2015;21(12):902-6.
  • Reutter, F. W. and Haase, W. [Clinical experience with silymarin in the treatment of chronic liver disease(author’s transl)]. Schweiz Rundsch.Med Prax. 9-9-1975;64(36):1145-1151.
  • Rotem C, Kaplan B. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol 2007;23:117-22.
  • Saberi Z, Gorji N, Memariani Z, Moeini R, Shirafkan H, Amiri M. Evaluation of the effect of Silybum marianum extract on menopausal symptoms: A randomized, double-blind placebo-controlled trial. Phytother Res. 2020.
  • Saller R, Brignoli R, Melzer J, Meier R. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementarmed 2008;15:9-20.
  • Salmi HA, Sarna S. Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind, controlled study. Scand J Gastroenterol 1982;17:517-21.
  • Savio, D., Harrasser, P. C., and Basso, G. Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomised study on silybin. Arzneimittelforschung. 1998;48(11):1104-1106.
  • Sayyah, M., Boostani, H., Pakseresht, S., and Malayeri, A. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder. Prog.Neuropsychopharmacol.Biol.Psychiatry 3-17-2010;34(2):362-365.
  • Schrieber, S. J., Hawke, R. L., Wen, Z., Smith, P. C., Reddy, K. R., Wahed, A. S., Belle, S. H., Afdhal, N. H., Navarro, V. J., Meyers, C. M., Doo, E., and Fried, M. W. Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C. Drug Metab Dispos. 2011;39(12):2182-2190.
  • Schrieber, S. J., Wen, Z., Vourvahis, M., Smith, P. C., Fried, M. W., Kashuba, A. D., and Hawke, R. L. The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activity. Drug Metab Dispos 2008;36(9):1909-1916.
  • Schriewer, H. and Rauen, H. M. [The effect of silybin dihemisuccinate on cholesterol biosynthesis in rat liver homogenates (author’s transl)]. Arzneimittelforschung. 1977;27(9):1691-1694.
  • Schroder, F. H., Roobol, M. J., Boeve, E. R., de Mutsert, R., Zuijdgeest-van Leeuwen, S. D., Kersten, I., Wildhagen, M. F., and van Helvoort, A. Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Eur Urol 2005;48(6):922-930.
  • Schuppan D, Strosser W, Burkard G, and et al. Influence of Legalon(TM) 140 on the metabolism of collagen in patients with chronic liver disease–Review by measurement of PIIINP-values. Zeitschrift fur Allgemeinmedizin 1998;74:577-584.
  • Seidlová-Wuttke D, Becker T, Christoffel V, Jarry H, Wuttke W. Silymarin is a selective estrogen receptor beta (ERbeta) agonist and has estrogenic effects in the metaphysis of the femur but no or antiestrogenic effects in the uterus of ovariectomized (ovx) rats. J Steroid Biochem Mol Biol. 2003;86(2):179-88.
  • Shahbazi F, Sadighi S, Dashti-Khavidaki S, et al. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytother Res. 2015;29(7):1046-53.
  • Shavandi M, Yazdani Y, Asar S, Mohammadi A, Mohammadi-Noori E, Kiani A. The Effect of Oral Administration of Silymarin on Serum Levels of Tumor Necrosis Factor-a and Interleukin-1ß in Patients with Rheumatoid Arthritis. Iran J Immunol 2022;19(4):427-435.
  • Shie Morteza M, Hayati Z, Namazi N, Abdollahimajd F. Efficacy and safety of oral silymarin in comparison with oral doxycycline and their combination therapy in the treatment of acne vulgaris. Dermatol Ther. 2019;32(6):e13095.
  • Skottova, N. and Krecman, V. Silymarin as a potential hypocholesterolaemic drug. Physiol Res 1998;47(1):1-7.
  • Soleymani S, Ayati MH, Mansourzadeh MJ, Namazi N, Zargaran A. The effects of Silymarin on the features of cardiometabolic syndrome in adults: A systematic review and meta-analysis. Phytother Res. 2022 Jan 11. doi: 10.1002/ptr.7364.
  • Somogyi, A., Ecsedi, G. G., Blazovics, A., Miskolczi, K., Gergely, P., and Feher, J. Short term treatment of type II hyperlipoproteinaemia with silymarin. Acta Med Hung. 1989;46(4):289-295.
  • Sonnenbichler J and Zetl I. Stimulating influence of a flavonolignane derivative on proliferation, RNA synthesis and protein synthesis in liver cells. In: Okoliczanyi L, Csomos G, Crepaldi G, and et al. Assessment and Management of Hepatobiliary Disease. Berlin: Springer-Verlag;1987.
  • Sonnenbichler J, Scalera F, Sonnenbichler I, Weyhenmeyer R. Stimulatory effects of silibinin and silicristin from the milk thistle Silybum marianum on kidney cells. J Pharmacol Exp Ther 1999;290:1375-83.
  • Sonnenbichler, J. and Zetl, I. Biochemical effects of the flavonolignane silibinin on RNA, protein and DNA synthesis in rat livers. Prog.Clin Biol Res 1986;213:319-331.
  • Sonnenbichler, J., Goldberg, M., Hane, L., Madubunyi, I., Vogl, S., and Zetl, I. Stimulatory effect of Silibinin on the DNA synthesis in partially hepatectomized rat livers: non-response in hepatoma and other malign cell lines. Biochem.Pharmacol 2-1-1986;35(3):538-541.
  • Soto, C. P., Perez, B. L., Favari, L. P., and Reyes, J. L. Prevention of alloxan-induced diabetes mellitus in the rat by silymarin. Comp Biochem Physiol C.Pharmacol Toxicol.Endocrinol. 1998;119(2):125-129.
  • Sridar C, Goosen TC, Kent UM, et al. Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases. Drug Metab Dispos 2004;32:587-94.
  • Sridharan K, Sivaramakrishnan G. Efficacy and safety of iron chelators in thalassemia and sickle cell disease: a multiple treatment comparison network meta-analysis and trial sequential analysis. Expert Rev Clin Pharmacol 2018;11(6):641-50. doi: 10.1080/17512433.2018.1473760.
  • Studlar M. Die Behandlung chronischer Leberkrankungen mit Silymarin und B-Vitaminen. Therapiewoche 1985;35:3375-3378.
  • Suksomboon N, Poolsup N, Boonkaew S, Suthisisang CC. Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes. J Ethnopharmacol 2011;137(3):1328-1333.
  • Szilard S, Szentgyorgyi D, Demeter I. Protective effect of Legalon in workers exposed to organic solvents. Acta Med Hung 1988;45:249-56.
  • Tanamly MD, Tadros F, Labeeb S, et al. Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results. Dig Liver Dis 2004;36:752-9.
  • Tiwari, P., Kumar, A., Balakrishnan, S., Kushwaha, H. S., and Mishra, K. P. Silibinin-induced apoptosis in MCF7 and T47D human breast carcinoma cells involves caspase-8 activation and mitochondrial pathway. Cancer Invest 2011;29(1):12-20.
  • Toomari E, Hajian S, Mojab F, Omidkhah T, Nasiri M. Evaluation of the effect of Silybum marianum ointment on episiotomy wound healing and pain intensity in primiparous women: a randomized triple blind clinical trial. BMC Complement Med Ther. 2021 Oct 7;21(1):253.
  • Tóth B, Németh D, Soós A, et al. The effects of a fixed combination of Berberis aristata and Silybum marianum on dyslipidaemia – A meta-analysis and systematic review. Planta Med. 2019.
  • Trinchet JC, Coste T, Levy VG. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients]. Gastroenterol Clin Biol 1989;13:120-4.
  • Tyutyulkova, N., Tuneva, S., Gorantcheva, U., Tanev, G., Zhivkov, V., Chelibonova-Lorer, H., and Bozhkov, S. Hepatoprotective effect of silymarin (carsil) on liver of D- galactosamine treated rats. Biochemical and morphological investigations. Methods Find.Exp Clin Pharmacol 1981;3(2):71-77.
  • Vailati A, Aristia L, Sozze E, and et al. Randomized open study of the dose-effect relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis. Fitoterapia 1993;64(3):219-228.
  • Valenzuela, A., Lagos, C., Schmidt, K., and Videla, L. A. Silymarin protection against hepatic lipid peroxidation induced by acute ethanol intoxication in the rat. Biochem.Pharmacol 6-15-1985;34(12):2209-2212.
  • van Erp NP, Baker SD, Zhao M, et al. Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan. Clin Cancer Res 2005;11:7800-6.
  • Velussi M, Cernigoi AM, De Monte A, et al. Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol 1997;26:871-9.
  • Velussi M, Cernigoi AM, Viezzoli L, and et al. Silymarin reduces hyperinsulinemia, malondialdehyde levels, and daily insulin need in cirrhotic diabetic patients. Curr Ther Res 1993;53(5):533-545.
  • Venkataramanan R, Ramachandran V, Komoroski BJ, et al. Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. Drug Metab Dispos 2000;28:1270-3.
  • Vidimce J, Pennell EN, Foo M, et al. Effect of silymarin treatment on circulating bilirubin and cardiovascular disease risk factors in healthy men: a single-blind, randomized crossover trial. Clin Pharmacol Drug Dev 2021.
  • Vidlar, A., Vostalova, J., Ulrichova, J., Student, V., Krajicek, M., Vrbkova, J., and Simanek, V. The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy – a six month placebo-controlled double-blind clinical trial. Biomed.Pap.Med.Fac.Univ Palacky.Olomouc.Czech.Repub. 2010;154(3):239-244.
  • Voroneanu L, Nistor I, Dumea R, Apetrii M, Covic A. Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2016;2016:5147468.
  • Vostalova J, Vidlar A, Ulrichova J, et al. Use of selenium-silymarin mix reduces lower urinary tract symptoms and prostate specific antigen in men. Phytomedicine 2013;21:75-81.
  • Wagoner, J., Morishima, C., Graf, T. N., Oberlies, N. H., Teissier, E., Pecheur, E. I., Tavis, J. E., and Polyak, S. J. Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation. PLoS.One. 2011;6(1):e16464.
  • Wah Kheong C, Nik Mustapha NR, Mahadeva S. A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2017;15(12):1940-1949.
  • Wallace, S., Vaughn, K., Stewart, B. W., Viswanathan, T., Clausen, E., Nagarajan, S., and Carrier, D. J. Milk thistle extracts inhibit the oxidation of low-density lipoprotein (LDL) and subsequent scavenger receptor-dependent monocyte adhesion. J Agric Food Chem 6-11-2008;56(11):3966-3972.
  • Wattanakrai P, Nimmannitya K. A Randomized, Double-Blind, Split-Face Study of Topical Silymarin vs 2% Hydroquinone Cream in Melasmas. J Drugs Dermatol 2022;21(12):1304-1310.
  • Wenzel, S., Stolte, H., and Soose, M. Effects of silibinin and antioxidants on high glucose-induced alterations of fibronectin turnover in human mesangial cell cultures. J Pharmacol Exp Ther 1996;279(3):1520-1526.
  • Weyhenmeyer, R., Mascher, H., and Birkmayer, J. Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay. Int.J Clin Pharmacol Ther Toxicol 1992;30(4):134-138.
  • Xiao F, Gao F, Zhou S, Wang L. The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction: A meta-analysis. Medicine (Baltimore). 2020;99(40):e22249.
  • Yakoot, M. and Salem, A. Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial. BMC.Gastroenterol. 2012;12:32.
  • Yang Z, Zhuang L, Lu Y, Xu Q, Chen X. Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials. Biomed Res Int. 2014;941085. doi: 10.1155/2014/941085. Epub 2014 Aug 27.
  • Zhang B, Jiang G, Wang L, et al. An analysis of silybin meglumine tablets in the treatment of drug-induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database. Br J Clin Pharmacol 2023;89(4):1329-1337.
  • Zhang, J. Q., Mao, X. M., and Zhou, Y. P. [Effects of silybin on red blood cell sorbitol and nerve conduction velocity in diabetic patients]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1993;13(12):725-6, 708.
  • Zhang, J., Luan, Q., Liu, Y., Lee, D. Y., and Wang, Z. A comparison of the diastereoisomers, silybin A and silybin B, on the induction of apoptosis in K562 cells. Nat.Prod.Commun. 2011;6(11):1653-1656.
  • Zhong S, Fan Y, Yan Q, et al. The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials. Medicine (Baltimore). 2017;96(49):e9061.
  • Zhu W, Zhang JS, Young CY. Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP. Carcinogenesis 2001;22:1399-403.
  • Zi, X., Mukhtar, H., and Agarwal, R. Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of mRNA expression of an endogenous tumor promoter TNF alpha. Biochem.Biophys.Res Commun. 10-9-1997;239(1):334-339.
  • Zima, T., Kamenikova, L., Janebova, M., Buchar, E., Crkovska, J., and Tesar, V. The effect of silibinin on experimental cyclosporine nephrotoxicity. Ren Fail. 1998;20(3):471-479.
  • Zou, C. G., Agar, N. S., and Jones, G. L. Oxidative insult to human red blood cells induced by free radical initiator AAPH and its inhibition by a commercial antioxidant mixture. Life Sci 5-25-2001;69(1):75-86.

Nettle

  • Anon. Quercetin. Alt Med Rev 1998;3:140-3.
  • Bakhshaee M, Mohammadpour AH, Esmaeili M, et al. Efficacy of a supportive therapy of allergic rhinitis by stinging nettle (Urtica dioica) root extract: a randomized, double-blind, placebo-controlled clinical trial. IJPR 2017;16(Special Issue):112-118.
  • Balzarini, J., Neyts, J., Schols, D., Hosoya, M., Van Damme, E., Peumans, W., and De Clercq, E. The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro. Antiviral Res 1992;18(2):191-207.
  • Baykul, T., Alanoglu, E. G., and Kocer, G. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience. J Contemp Dent Pract 2010;11(1):E088-E094.
  • Bercovich, E. and Saccomanni, M. Analysis of the results obtained with a new phytotherapeutic association for LUTS versus control. [corrected]. Urologia. 2010;77(3):180-186.
  • Beyazit, Y., Kurt, M., Kekilli, M., Goker, H., and Haznedaroglu, I. C. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern.Med.Rev. 2010;15(4):329-336.
  • Bombardelli E and Morazzoni P. Urtica dioica L. Fitoterapia 1997;68(5):387-402.
  • Cabeza M, Bratoeff E, Heuze I, et al. Effect of beta-sitosterol as inhibitor of 5 alpha-reductase in hamster prostate. Proc West Pharmacol Soc 2003;46:153-5.
  • Cai, T., Mazzoli, S., Bechi, A., Addonisio, P., Mondaini, N., Pagliai, R. C., and Bartoletti, R. Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study. Int.J Antimicrob.Agents 2009;33(6):549-553.
  • Caliskaner Z, Karaayvaz M, Ozturk S. Misuse of a herb: stinging nettle (Urtica urens) induced severe tongue oedema. Complement Ther Med 2004;12:57-8.
  • Christensen, R. and Bliddal, H. Is Phytalgic(R) a goldmine for osteoarthritis patients or is there something fishy about this nutraceutical? A summary of findings and risk-of-bias assessment. Arthritis Res.Ther. 2010;12(1):105.
  • Chrubasik S, Enderlein W, Bauer R, and Grabner W. Evidence for antirheumatic effectiveness of Herba Urticae dioicae in acute arthritis: A pilot study. Phytomedicine 1997;4(2):105-108.
  • Chrubasik, J. E., Roufogalis, B. D., Wagner, H., and Chrubasik, S. A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix. Phytomedicine. 2007;14(7-8):568-579.
  • Chrubasik, J. E., Roufogalis, B. D., Wagner, H., and Chrubasik, S. A. A comprehensive review on nettle effect and efficacy profiles, Part I: herba urticae. Phytomedicine. 2007;14(6):423-435.
  • Czarnetzki, B. M., Thiele, T., and Rosenbach, T. Immunoreactive leukotrienes in nettle plants (Urtica urens). Int Arch Allergy Appl.Immunol. 1990;91(1):43-46.
  • Dathe G and Schmid H. [Phytotherapy of the benign prostatic hyperplasia (BPH). Double-blind study with an extract of Radicus Urticae (ERU)]. Urologe B 1987;27:223-226.
  • Durak I, Biri H, Devrim E, et al. Aqueous extract of Urtica dioica makes significant inhibition on adenosine deaminase activity in prostate tissue from patients with prostate cancer. Cancer Biol Ther 2004;3:855-7.
  • Easton L, Vaid S, Nagel AK, Venci JV, Fortuna RJ. Stinging Nettle (Urtica dioica): An Unusual Case of Galactorrhea. Am J Case Rep 2021;22:e933999.
  • Engelmann U, Boos G, and Kres H. [Therapy of benign prostatic hyperplasia with Bazoton liquidum]. Urologe B 1996;36:287-291.
  • Eyi, E. G., Engin-Ustun, Y., Kaba, M., and Mollamahmutoglu, L. Ankaferd blood stopper in episiotomy repair. Clin Exp Obstet Gynecol 2013;40(1):141-143.
  • Farzami B, Ahmadvand D, Vardasbi S, Majin FJ, Khaghani Sh. Induction of insulin secretion by a component of Urtica dioica leave extract in perifused Islets of Langerhans and its in vivo effects in normal and streptozotocin diabetic rats. J Ethnopharmacol. 2003;89(1):47-53.
  • Fischer M and Wilbert D. [Efficacy testing of a phytopharmacon in the treatment of benign prostate hyperplasia (BPH)]. In: Rutishauser G. Benigne Prostatahyperplasie. Munchen: Zuckerscherdt;1992.
  • Francois, K. O., Auwerx, J., Schols, D., and Balzarini, J. Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development. Mol.Pharmacol. 2008;74(2):330-337.
  • Gansser D and Spiteller G. Aromatase inhibitors from Urtica dioica roots. Planta Medica 1995;61:138-140.
  • Goetz P. [Treatment of benign prostate hyperplasia with nettle roots]. Zeitschrift für Phytotherapie 1989;10:175-178.
  • Hallwachs, O. [Urination disorders caused by prostatic hyperplasia. Effect of Bazoton, Harzol and Prosta-capsules]. MMW.Munch.Med Wochenschr. 10-30-1981;123(44):1675-1676.
  • Hartmann RW, Mark M, and Soldati F. Inhibition of a 5 a-reductase and aromatase by PHL-00801 (Prostatonin®), a combination of PY102 (Pygeum africanum) and UR 102 (Urtica dioica) extracts. Phytomedicine 1996;3(2):121-128.
  • Hill, N., Stam, C., and van Haselen, R. A. The efficacy of Prrrikweg gel in the treatment of insect bites: a double-blind, placebo-controlled clinical trial. Pharm World Sci 1996;18(1):35-41.
  • Hill, N., Stam, C., Tuinder, S., and van Haselen, R. A. A placebo controlled clinical trial investigating the efficacy of a homeopathic after-bite gel in reducing mosquito bite induced erythema. Eur J Clin Pharmacol 1995;49(1-2):103-108.
  • Hirano, T., Homma, M., and Oka, K. Effects of stinging nettle root extracts and their steroidal components on the Na+,K(+)-ATPase of the benign prostatic hyperplasia. Planta Med 1994;60(1):30-33.
  • Hryb, D. J., Khan, M. S., Romas, N. A., and Rosner, W. The effect of extracts of the roots of the stinging nettle (Urtica dioica) on the interaction of SHBG with its receptor on human prostatic membranes. Planta Med 1995;61(1):31-32.
  • Huber, R., Bross, F., Schempp, C., and Grundemann, C. Arnica and stinging nettle for treating burns – a self-experiment. Complement Ther.Med. 2011;19(5):276-280.
  • Jacquet, A., Girodet, P. O., Pariente, A., Forest, K., Mallet, L., and Moore, N. Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial. Arthritis Res.Ther. 2009;11(6):R192.
  • Kassen A, Berges R, Senge T, et al. Effect of beta-sitosterol on transforming growth factor-beta-1 expression and translocation protein kinase C alpha in human prostate stromal cells in vitro. Eur Urol 2000;37:735-41.
  • Khalili N, Fereydoonzadeh R, Mohtashami R, Mehrzadi S, Heydari M, Huseini F. Silymarin, Olibanum, and Nettle, a mixed herbal formulation in the treatment of Type II Diabetes: a randomized, double-blind, placebo-controlled, clinical trial. J Evid Based Complementary Altern Med. 2017 Oct;22(4):603-608.
  • Khosravi MH, Atefi A, Mehri A, et al. Therapeutic effects of Rosa canina, Urtica dioica and Tanacetum vulgare herbal combination in treatment of tinnitus symptoms: A double-blind randomised clinical trial. Clin Otolaryngol 2022.
  • Kianbakht S, Khalighi-Sigaroodi F, Dabaghian FH. Improved glycemic control in patients with advanced type 2 diabetes mellitus taking Urtica dioica leaf extract: a randomized double-blind placebo-controlled clinical trial. Clin. Lab. 2013;59:1071-1076.
  • Klingelhoefer, S., Obertreis, B., Quast, S., and Behnke, B. Antirheumatic effect of IDS 23, a stinging nettle leaf extract, on in vitro expression of T helper cytokines. J Rheumatol. 1999;26(12):2517-2522.
  • Koch, E. Extracts from Fruits of Saw Palmetto (Sabal serrulata) and Roots of Stinging Nettle (Urtica dioica): Viable Alternatives in the Medical Treatment of Benign Prostatic Hyperplasia and Associated Lower Urinary Tracts Symptoms. Planta Med 2001;67(6):489-500.
  • Konieczynski, P. and Wesolowski, M. Water-extractable magnesium, manganese and copper in leaves and herbs of medicinal plants. Acta Pol.Pharm. 2012;69(1):33-39.
  • Konrad L, Muller HH, Lenz C, et al. Antiproliferative effect on human prostate cancer cells by a stinging nettle root (Urtica dioica) extract. Planta Med 2000;66:44-7.
  • Kraus R, Spiteller G, and Bartsch W. [(10E,12Z)-9-Hydroxy-10,12-octadecadienoic acid, an aromatase inhibitor from roots of Urtica dioica]. Liebigs Ann Chem 1991;335-339.
  • Krystofova O, Adam V, Babula P, et al. Effects of Various Doses of Selenite on Stinging Nettle (Urtica dioica L.). Int J Environ Res Public Health. 2010 Oct;7(10):3804-15.
  • Krzeski, T., Kazon, M., Borkowski, A., Witeska, A., and Kuczera, J. Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses. Clin Ther 1993;15(6):1011-1020.
  • Kulze, A. and Greaves, M. Contact urticaria caused by stinging nettles. Br.J Dermatol. 1988;119(2):269-270.
  • Lichius J. J., Muth C. The inhibiting effects of Urtica dioica root extracts on experimentally induced prostatic hyperplasia in the mouse. Planta Med 1997;63:307-10.
  • Lichius, J. J., Lenz, C., Lindemann, P., Muller, H. H., Aumuller, G., and Konrad, L. Antiproliferative effect of a polysaccharide fraction of a 20% methanolic extract of stinging nettle roots upon epithelial cells of the human prostate (LNCaP). Pharmazie 1999;54(10):768-771.
  • Lopatkin N, Sivkov A, Walther C, et al. Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms–a placebo-controlled, double-blind, multicenter trial. World J Urol 2005;23:139-46.
  • Lopatkin, N. A., Sivkov, A. V., Medvedev, A. A., Walter, K., Schlefke, S., Avdeichuk, IuI, Golubev, G. V., Mel’nik, K. P., Elenberger, N. A., and Engelman, U. [Combined extract of Sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in double blind, placebo-controlled trial]. Urologiia. 2006;(2):12, 14-12, 19.
  • Lopatkin, N. A., Sivkov, A. V., Schlafke, S., Funk, P., Medvedev, A., and Engelmann, U. Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms–long-term follow-up of a placebo-controlled, double-blind, multicenter trial. Int.Urol.Nephrol. 2007;39(4):1137-1146.
  • Luczaj, L. and Szymanski, W. M. Wild vascular plants gathered for consumption in the Polish countryside: a review. J.Ethnobiol.Ethnomed. 2007;3:17.
  • Maor D, Little M. Skin contact with a stinging tree requiring intensive care unit admission. Contact Dermatitis. 2017 Nov;77(5):335-37.
  • Marks L, Partin AW, Epstein JI, et al. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol 2000;163:1451-6.
  • Men C, Wang M, Aiyireti M, Cui Y. The efficacy and safety of Urtica dioica in treating benign prostatic hyperplasia: a systematic review and meta-analysis. Afr J Tradit Complement Alt Med 2016;13(2):143-50.
  • Mills S, Bone K. Principles and Practice of Phytotherapy. London: Churchill Livingstone, 2000.
  • Mittman P. Randomized, double-blind study of freeze-dried Urtica dioica in the treatment of allergic rhinitis. Planta Med 1990;56:44-7.
  • More M, Gruenwald J, Pohl U, Uebelhack R. A Rosa canina – Urtica dioica – Harpagophytum procumbens/zeyheri combination significantly reduces gonarthritis symptoms in a randomized, placebo-controlled double-blind study. Planta Med. 2017 Dec;83(18):1384-91.
  • Najafipour F, Rahimi AO, Mobaseri M, Agamohamadzadeh N, Nikoo A, Aliasgharzadeh A. Therapeutic effects of stinging nettle (Urtica dioica) in women with hyperandrogenism. Int J Curr Res Aca Rev. 2014;2(7):153-160.
  • Namazi, N., Esfanjani, A. T., Heshmati, J., and Bahrami, A. The effect of hydro alcoholic Nettle (Urtica dioica) extracts on insulin sensitivity and some inflammatory indicators in patients with type 2 diabetes: a randomized double-blind control trial. Pak.J.Biol.Sci. 8-1-2011;14(15):775-779.
  • Obertreis, B., Ruttkowski, T., Teucher, T., Behnke, B., and Schmitz, H. Ex-vivo in-vitro inhibition of lipopolysaccharide stimulated tumor necrosis factor-alpha and interleukin-1 beta secretion in human whole blood by extractum urticae dioicae foliorum. Arzneimittelforschung 1996;46(4):389-394.
  • Oliver, F., Amon, E. U., Breathnach, A., Francis, D. M., Sarathchandra, P., Black, A. K., and Greaves, M. W. Contact urticaria due to the common stinging nettle (Urtica dioica)– histological, ultrastructural and pharmacological studies. Clin Exp Dermatol. 1991;16(1):1-7.
  • Onal S, Timur S, Okutucu B, Zihnioglu F. Inhibition of alpha-glucosidase by aqueous extracts of some potent antidiabetic medicinal herbs. Prep Biochem Biotechnol. 2005;35(1):29-36.
  • Patten G. Medicinal plant review: Urtica. Aust J Med Herbalism 1993;5(1):5-13.
  • Pavone, C., Abbadessa, D., Tarantino, M. L., Oxenius, I., Lagana, A., Lupo, A., and Rinella, M. [Associating Serenoa repens, Urtica dioica and Pinus pinaster. Safety and efficacy in the treatment of lower urinary tract symptoms. Prospective study on 320 patients]. Urologia. 2010;77(1):43-51.
  • Purnak, T., Ozaslan, E., Beyazit, Y., and Haznedaroglu, I. C. Upper gastrointestinal bleeding in a patient with defective hemostasis successfully treated with ankaferd blood stopper. Phytother.Res. 2011;25(2):312-313.
  • Randall C, Randall H, Dobbs F, et al. Randomized controlled trial of nettle sting for treatment of base-of-thumb pain. J R Soc Med 2000;93:305-9.
  • Randall, C. F. Stinging nettles for osteoarthritis pain of the hip. Br.J Gen.Pract. 1994;44(388):533-534.
  • Randall, C., Dickens, A., White, A., Sanders, H., Fox, M., and Campbell, J. Nettle sting for chronic knee pain: a randomised controlled pilot study. Complement Ther.Med. 2008;16(2):66-72.
  • Randall, C., Meethan, K., Randall, H., and Dobbs, F. Nettle sting of Urtica dioica for joint pain–an exploratory study of this complementary therapy. Complement Ther Med 1999;7(3):126-131.
  • Rau O, Wurglics M, Dingermann T, Abdel-Tawab M, Schubert-Zsilavecz M. Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor. Pharmazie. 2006;61(11):952-6.
  • Rayburn, K., Fleischbein, E., Song, J., Allen, B., Kundert, M., Leiter, C., and Bush, T. Stinging nettle cream for osteoarthritis. Altern.Ther.Health Med. 2009;15(4):60-61.
  • Rhodes, L., Primka, R. L., Berman, C., Vergult, G., Gabriel, M., Pierre-Malice, M., and Gibelin, B. Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition. Prostate 1993;22(1):43-51.
  • Riehemann, K., Behnke, B., and Schulze-Osthoff, K. Plant extracts from stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF-kB. FEBS Lett 1-8-1999;442(1):89-94.
  • Safarinejad, M. R. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study. J.Herb.Pharmacother. 2005;5(4):1-11.
  • Sahin, M., Yilmaz, H., Gursoy, A., Demirel, A. N., Tutuncu, N. B., and Guvener, N. D. Gynaecomastia in a man and hyperoestrogenism in a woman due to ingestion of nettle (Urtica dioica). N.Z.Med.J. 2007;120(1265):U2803.
  • Schneider H, Honold E, and Masuhr T. Treatment of benign prostatic hyperplasia with a combination plant preparation. Results of an observational study of sabal extract WS 1473 and Urtica extract WS 1031 in the offices of urologists. Fortschr Med 1995;113(3):37-40.
  • Schneider, T. and Rubben, H. [Stinging nettle root extract (Bazoton-uno) in long term treatment of benign prostatic syndrome (BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months]. Urologe A 2004;43(3):302-306.
  • Schottner M, Gansser D, Spiteller G, et al. Lignans from the roots of Urtica dioica and their metabolites bind to human sex hormone binding globulin (SHBG). Planta Med 1997;63:529-32.
  • Schöttner M, Spiteller G, Gansser D. Lignans Interfering with 5alpha-dihydrotestosterone binding to human sex hormone-binding globulin. J Nat Prod. 1998;61(1):119-21.
  • Simões-Pires CA, Hmicha B, Marston A, Hostettmann K. A TLC bioautographic method for the detection of alpha- and beta-glucosidase inhibitors in plant extracts. Phytochem Anal. 2009;20(6):511-5.
  • Sokeland J, Albrecht J. [Combination of Sabal and Urtica extract vs. finasteride in benign prostatic hyperplasia (Aiken stages I to II). Comparison of therapeutic effectiveness in a one year double-blind study]. Urologe A 1997;36:327-33.
  • Sokeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. BJU Int 2000;86:439-42.
  • Tabrizi R, Sekhavati E, Nowrouzi-Sohrabi P, et al. Effects of Urtica dioica on Metabolic Profiles in Type 2 Diabetes: A Systematic Review and Meta-analysis of Clinical Trials. Mini Rev Med Chem 2022;22(3):550-563.
  • Tahri, A., Yamani, S., Legssyer, A., Aziz, M., Mekhfi, H., Bnouham, M., and Ziyyat, A. Acute diuretic, natriuretic and hypotensive effects of a continuous perfusion of aqueous extract of Urtica dioica in the rat. J Ethnopharmacol 2000;73(1-2):95-100.
  • Van der Weijden, G. A., Timmer, C. J., Timmerman, M. F., Reijerse, E., Mantel, M. S., and van, der, V. The effect of herbal extracts in an experimental mouthrinse on established plaque and gingivitis. J Clin Periodontol. 1998;25(5):399-403.
  • Van Parijs J, Broekaert WF, and Peumans WJ. Urtica dioica agglutinin: a plant lectin with antifungal properties. Archives Internationales de Physiologie et de Biochimie 1988;96(1):31.
  • Vontobel HP, Herzog R, Rutishauser G, Kres H. [Results of a double-blind study on the effectiveness of ERU (extractum radicis Urticae) capsules in conservative treatment of benign prostatic hyperplasia]. (Abstract). Urologe A 1985;24:49-51.
  • Wagner H, Geiger WN, Boos G, and et al. Studies on the binding of Urtica dioica agglutinin (UDA) and other lectins in an in vitro epidermal growth factor receptor test. Phytomedicine 1995;4:287-290.
  • Wagner H, Willer F, Samtleben R, and et al. Search for the antiprostatic principle of stinging nettle (Urtica dioica) roots. Phytomedicine 1994;1:213-224.
  • Younger J, Donovan EK, Hodgin KS, Ness TJ. A placebo-controlled, pseudo-randomized, crossover trial of botanical agents for Gulf war illness: Reishi mushroom (Ganoderma lucidum), stinging nettle (Urtica dioica), and Epimedium (Epimedium sagittatum). Int J Environ Res Public Health 2021;18(7):3671.
  • Ziaei R, Foshati S, Hadi A, et al. The effect of nettle (Urtica dioica) supplementation on the glycemic control of patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Phytother Res 2020;34(2):282-94.

Conditions Of Use And Important Information

This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on website. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

2 reviews for Fistful of Weeds™ 50g

  1. George Chapman

    This was a unexpected pleasure. I tried the tea as a laugh at the flower show, but I love it. I’ve been drinking one cup a day since then.

  2. Clara

    I bought this tea after tasting it at the Oxford Foodies festival – it was amazing and continues to refresh me. I was told it was a great detoxifier, and I do think I feel a lot better. I am running low and have just placed another order. Thank you for this wonderful tea.

Add a review